While Science Sleeps Bibliography

*FAIR USE NOTICE: This posting may contain some copyrighted © material the use of which has not always been specifically authorized by the copyright owner. Such material is made available for educational purposes, to advance recipient's understanding of scientific and other issues. It is believed that this posting is a 'fair use' of any such copyrighted material as provided for in Title 17 U.S.C. section 107 of the US intellectual property law. This material is being distributed without profit.

1.  Monte WC. Aspartame; Methanol and the Public Health. Journal of Applied Nutrition 1984;36(1):42-58. 
2.  Monte W, Glanzman D, Johnston C. Methanol as a Model Etiologic Agent Multiple Sclerosis. FASEB 1990;26(4(3)):Abstract. 
3.  Roe O. Methanol Poisoning Its clinical course pathogenesis and treatment. Acta Medica Scandinavica 1946;126:1-252. 
4.  Kallen R, Jencks W. Equilibria for the Reaction of Amines with Formaldehyde and Protons in Aqueous Solution. J Biol Chem 1966;241(24):5864. 
5.  Henzi H. The Methanol Hypothesis A New Concept of Multiple Sclerosis:. M Sr N ed. Zurich: Juris Druck; 1980. 
6.  Schwyzer R, Henzi H. Multiple Sclerosis: Plaques Caused by 2-Step Demyelination? Med Hypothesis 1983;12:129-42. 
7.  Trocho C, Pardo R, Fafecas I, Virgili J, Remesar X, Fernandez-Lopez JA, et al. Formaldehyde derived from dietary aspartame binds to tissue components in vivo. Life Sci 1988;63(5):337-49. 
8.  Henzi H. Chronic Methanol Poisoning with the Clinical and Pathologic-Anatomical Features of Multiple Sclerosis Medical Hypothesis. Med Hypothesis 1984;13:63-75. 
9.  Hazra D, Seth H, Mathur K, Wahal P, Prakash V, Maheshwari B, et al. Electrocardiographic Changes in Acute Methanol Poisoning. J.Assoc.Physicians India 1974;22:409-13. 
10.  Schwyzer R, Henzi H. Multiple Sclerosis: Prevention of Serious Illness - Vision of a Desired Future for Newly Ascertained Patients. Med Hypothesis 1992;37:115-8. 
11.  Rousseau M, Straif K, Siemiatycki J. IARC Carcinogen Update(Formaldehyde now Class 1 carcinogen). Environmental Health Perspectives 2005;113(9):A580. 
12.  Apol A. Health Hazard Evaluation Report. PB82-19464 8. University of Washington Seattle. Washington. NIOSH U. S .Dept. of Health and Human Services; 1981. 
13.  Lauer K. Risk of multiple sclerosis in relation to industrial activities: an ecological study in four European countries. Neuroepidemiology 1989;8(1):38-42. 
14.  G.D. Searle Co. Aspartame for use as a Sweetener in Carbonated Beverages. Searle Research and Development. Petition submitted to the US Food and Drug Administration. United States Food and Drug Administration; 1983. 
15.  Eisenberg A. Visceral Changes in Wood Alcohol Poisoning by Inhalation. American Journal of Public Health 1917;7:765-71 
16.  Bennett I, Cary F, Michell G, Cooper M. Acute Methyl Alcohol Poisoning; A Review Based on Experience in an Outbreak of 323 Cases. Medicine 1953;32:431-57. 
17.  Wimer W, Russell J, Kaplan H. Alcohols Toxicology History. Southwest Research Institute San Antonio TX: Noyes Data Corporation.; 1983 
18.  Gaul H, Wallace C, Auer R. MR findings in methanol intoxication. Am J Neuroradiol 1995;16:1783-6. 
19.  Francot P, Geoffroy P. Le Methanol dans les jus de fruits. les boissons. fermentees. les alcools et spiritueux. Revue Des Fermentations Et Des Industries Alimentaires. 1956;11:279-86. 
20.  Davoli F, Cappellini L, Airoldi L, Fanelli R. Serum methanol concentrations in rats and in men after a single dose of aspartame. Food Chem Toxicol. 24(3):187 1986;24(3):187. 
21.  Schneck S. Methyl alcohol. In: Vinken P, Bruyn G, editors. Handbook of Clinical Neurology. Amsterdam: North-Holland; 1989. p. 351-60. 
22.  Weisberger A, MacLaughlin J. Electrocardiographic Changes Associated with Methyl Alcohol Poisoning. American Heart Journal 1946;33:27-33. 
23.  Horiuchi S, Takata K, Morino Y. Scavenger Receptor for Aldehyde-modified Proteins. The Journal of Biological Chemistry 1986;261(11):4962. 
24.  Horiuchi S, Takata K, Morino Y. Purification of a Receptor for Formaldehyde-treated Serum Albumin from Rat Liver. The Journal of Biological Chemistry. 260(1):482 1985;260(1):482-88. 
25.  Horiuchi S, Takata K, Morino Y. Characterization of a Membrane-associated Receptor from Rat Sinusoidal Liver Cells That Binds Formaldehyde-treated Serum Albumin. The Journal of Biological Chemistry 1985;260(1):475-81. 
26.  Metz B, Jiskoot W, Hennink W, Crommelin D, Kersten G. Physicochemical and immunochemical techniques predict the quality of diphtheria toxoid vaccines. Vaccine 2003;22:156-67. 
27.  Means G, Feeney R. Chemical Modification of Proteins (formaldehyde hydrate). Francisco, CA.: Holden-Day, Inc; 1971. 
28.  Kirchner J, Miller J. Volatile Water-Soluble and Oil Constituents of Valencia Orange Juice. Agricultural and Food Chemistry 1957;5(4):283. 
29.  Lund E, Kirkland C, Shaw P. Methanol. Ethanol. and Acetaldehyde Contents of Citrus Products. Agricultural and Food Chemistry 1981;29:361. 
30.  Koivusalo M. Studies on the Metabolism of Methanol and Formaldehyde in the Animal Organism. Acta Physiologica Scandinavica 1956;39:1. 
31.  Buys C, De Jong C, Bouma J, Gruber M. Rapid Uptake by Liver Sinusoidal Cells of Serum Albumin Modified with Retention of its Compact Conformation. Biochimica Et Biophysica Acta 1975;392:95. 
32.  Buys C, Elferink G, Bouma J, Gruber M, Nieuwenhuis P. Proteolysis of Formaldehyde-treated Albumin in Kupffer Cells and Its Inhibition by Suramin. Journal of the Reticuloendothelial Society 1973;14:209. 
33.  Gruner O, Bilzer N. Methanol content of fruit-juices. Its significance in congener analysis. Blutalkohol 1983;20:241. 
34.  Casey J, Self R, Swain T. Origin of Methanol and Dimethyl Sulphide from Cooked Foods. Nature 1963;200:885. 
35.  Braverman J, Lifshitz A. Pectin Hydrolysis in Certain Fruits during Alcoholic Fermentation. Food Technology 1957(July):356-58. 
36.  Campbell L, Palmer G. Pectin. In: Spiller G, Amen R, editors. Topics in Dietary Fiber Research. New York: Plenum Press.; 1994. p. 105. 
37.  Fink W. The ocular pathology of methyl-alcohol poisoning. Amer J Ophthal 1942;26:694. 
38.  Millman R. Alcohol; The Friendly Foe. In: Science Year. The World Book Science Annual; 1982. p. 112-20. 
39.  Gordon G. NutraSweet Questions Swirl (How Sweet It Isn’t a UPI Investigative Report ). Seattle Times. Seattle, Wash. Oct 13, 1987. p. F1: United Press International; 1987. 
40.  Tephly T. Comments on the purported generation of formaldehyde from the sweetener aspartame [letter: not peer-reviewed]. Life Sci 1999;65:157-60. 
41.  Lutton J, Winston R, Rodman T. Multiple Sclerosis: Etiological Mechanisms and Future Directions. Experimental Biology and Medicine 2004;229:12-20. 
42.  Heinzow B. Formic acid in urine--a significant parameter in environmental diagnosis? Zentralbl Hyg Umweltmed 1992;192(5):455-61. 
43.  Alexander L, Berkeley A, Alexander A. Multiple Sclerosis Prognosis and Treatment. Illinois: Charles C .Thomas Publisher; 1961. 
44.  Hallpike J, Adams C, Tourtellotte W. Multiple Sclerosis, Pathology, diagnosis and management. Baltimore: Williams & Wilkins.; 1983. 
45.  Multiple Sclerosis Trust. History of MS. 2007. Available from: URL: 
46.  Westler Foods Corp. The History of Food Canning. 2007. Available from: URL: 
47.  Gold M. Scientific Abuse in Methanol / Formaldehyde Research related to Aspartame 2008. Available from: URL: 
48.  G.D. Searle Co. Aspartame for use as a Sweetener in Carbonated Beverages. Searle Research and Development. Petition submitted to the US FDA. United States Food and Drug Administration; 1983. 
49.  Westline T. Methanol Warning Sign.: T&B Westline; 1965. 
50.  Soffritti M, Belpoggi F, Tibaldi E, Espost iD, Lauriola M. Lifespan Exposure to Low Doses of Aspartame Beginning During Prenatal Life Increases Cancer Effects in Rats. Environmental Healt Perspectives, National Institute of Health 2007. 
51.  Soffritti M, Belpoggi F, Cevolani D, Guarino M, Padovani M, Maltoni C. Results of Long-Term Results of Long-Term Experimental Studies on the Carcinogenicity of Methyl Alcohol and Ethyl Alcohol in Rats. N.Y. Acad. Sci. 2002;982:46. 
52.  Roe O. Species Differences in Methanol Poisoning. I. Minimal Lethal Doses. Symptoms. and Toxic Sequelae of Methanol Poisoning in Humans and Experimental Animals. CRC Critical Reviews in Toxicology 1982;18:376-90. 
53.  Rao K, Aurora A, Muthaiyan S, Ramakrishnan S. Methanol toxicity - an experimental study. Bull Jawaharlal Inst Post-Grad Med Educ Res 1977;2:1. 
54.  Walton RG, Hudak R, Green-Waite R. Adverse Reactions to Aspartame: Double-Blind Challenge in Patients from a Vulnerable Population. Biological Psychiatry 1993;34:13. 
55.  Smith E, Taylor R. Acute Toxicity of Methanol in the Folate-Deficient Acatalasemic Mouse. Toxicology 1982;25:271. 
56.  Thomas P. Aspartame: The Shocking Story of the World’s Bestselling Sweetener. The Ecologist 2005;36(Sept.). 
57.  Nauta W, Lampert P, Yount V. Decision of the Public Board of Inquiry ,Department of Health and Human Services. 44 Fed. Reg. 31716: U.S. Food and Drug Administration; 1979. 
58.  Center for Disease Control. Center for Disease Control 1984. Evaluation of Consumer Complaints Related to Aspartame Use. Morbidity and Mortality Weekly Report. 33:605. 1984. 
59.  Center for Disease Control. Center for Disease Control 1976. Occupational Exposure to Methyl Alcohol. U.S. Department of Health. Education. and Welfare.; 1976. 
60.  Hodgson P. Office of Hon Pete Hodgson. NZ Minister of Health. 2007. Personal Communication.; 2007. 
61.  Frankenburg W. Chemical Changes in the Harvested Tobacco Leaf. Part II. Chemical and Enzymic Conversions during Fermentation and Aging. Advances in Enzymology. 10:351 1950;10:351. 
62.  Neuberg C, Kobel M. Uber die encymatische Abspaltung von Methylalkohol aus Pektin durch ein Ferment dis Tabaks. Zeitschrift Für Lebensmitteluntersuchung Und -Forschung A 1939;77(3):272. 
63.  Newsome J, Normal V, Keith C. Vapor Phase Analysis of Cigarette Smoke. Tobacco Science 9:102 1965;9:102. 
64.  Larsson B. Gas Chromatography of Organic Volatiles in Human Breath and Saliva. Acta Chemica Scandinavica 1965;19:159-64. 
65.  Fellenberg T. Uber den Nachweis und die Bestimmung des Methylalkohols. sein Vorkommen in den verschiedenen Nahrungsmitteln und das Verhalten der methylalkoholhaltland. Biochem Z 1918;85:45-117. 
66.  Kertesz Z. The Pectic Substances. New York: Interscience Publishers Inc.; 1951. 
67.  Hernan M, Olek M, Ascherio A. Cigarette Smoking and Incidence of Multiple Sclerosis. American Journal of Epidemiology 2001;154(1):69-74. 
68.  Hernan M, Jick S, Logroscino G, Olek M, Ascherio A, Jick H. Cigarette smoking and the progression of multiple sclerosis. Brain 2005;128(6):1461-65. 
69.  Lauer K. Multiple sclerosis in relation to meat preservation in France and Switzerland. Neuroepidemiology 1989;8(6):308-15. 
70.  In Tech. Turning Waste To Profit. 2001. Available from: URL: 
71.  Nortvedt M, Riise T, Maeland J. Multiple sclerosis and lifestyle factors: The Hordaland Health Study. Neurol Sci 2005;26:334-39. 
72.  Bamford R, Sibley W, Thies C. Seasonal variation of multiple sclerosis exacerbations in Arizona. Neurology 1983;33:697-701. 
73.  Hardy C, Palmer B, Muir K, Sutton A, Powell R. Smoking history. alcohol consumption. and systemic lupus erythematosus: a case-control study. Ann Rheum Dis 1998;57:451-5. 
74.  Landtblom A, Flodin U, Sodeifeldt B, Wolfson C, Axelson O. Organic Solvents and Multiple Sclerosis: A Synthesis of the Current Evidence. Epidemiology 1996;7(4):429-33. 
75.  Grabenstein J. ImmunoFacts: Vaccines & Immunologic Drugs. St. Louis. MO.: Wolters Kluwer Health Inc.; 2006. 
76.  Weiner H, Dau P, Khatri B, Petajan J, Birnbaum G, McQuillen M, et al. Double-blind study of true vs. sham plasma exchange in patients treated with immunosuppression for acute attacks of multiple sclerosis. Neurology. 1989;39(9):1143-9. 
77.  Hirtz D, Thurman D, Gwinn-Hardy K, Mohamed M, Chaudhuri A, Zalutsky R. How common are the “common” neurologic disorders? Neurology 2007;68:326-37. 
78.  Monte W. Sickly Sweet: Is your Diet Sweetener Killing You? Fitness Life 2007;33:30-3. 
79.  Corona T, Roman G. Multiple Sclerosis in Latin America. Neuroepidemiology 2005;26:1-3. 
80.  Grimaldi L, Palmeri B, Salemi G, Giglia G, D’Amelio M, Grimaldi R. High prevalence and fast rising incidence of multiple sclerosis in Caltanissetta. Sicily. southern Italy. Neuroepidemiology. 2007;28(1):28-32. 
81.  Kira J. Epidemiology of multiple sclerosis in Japanese: with special reference to opticopsinal multiple sclerosis. Rinsho Shinkeigaku. 2006;46(11):859-62. 
82.  Lauer K. Ditary Changes in Temporal Relation to Multiple Sclerosis in the Faroe Islands: An Evaluation of Literary Sources. Neuroepidemiology 1989;8:200-6. 
83.  Lazoff M. Multiple Sclerosis Symptoms. 2005. Available from: URL: 
84.  Waksman B. Mechanisms in multiple sclerosis. Nature 1985;318:104. 
85.  Leibowitz U, Alter M. Multiple Sclerosis: Clues to its cause.: North-Holland Publishing Co.; 1973. 
86.  Saha A, Khudabaksh A. Aberrations Induced by Methanol in Germinal Cells of Grasshopper. Oxya velox Fabricius. Indian J Exper Biol 1974;12:72. 
87.  DeLuca J. Alcohol and Health. Fourth Special Report to the U.S. Congress Secretary of Health and Human Services. Secretary of Health and Human Services; 1981. 
88.  Roe O. The Metabolism and Toxicity of Methanol. Parmacological Review 1955;7:399-412. 
89.  Bingham E. Expert Panel Report, Human Reproductive and Developmental Toxicity of Methanol Toxicity of Methanol. Draft with important internal comment. U.S. Department of Health & Human Services National Toxicology Program; 2001. 
90.  Gallegher L, Lea R. The epidemiology of multiple sclerosis in New Zealand. The New Zealand Medical Journal 2005;118:1212-3. 
91.  Boyles S. MS Increasingly a Woman’s Disease. MedicineNet.comChanges in the Sex Ratio over Time in Multiple Sclerosis, 59th Annual meeting of the American Academy of Neurology, Boston Cutter, G. et al 2007. Available from: URL: 
92.  Burbacher T, Grant K, Shen D. Reproductive and offspring Developmental Effects Following Maternal Inhalation Exposure to Methanol in Nonhuman Primates. Health Effects Institute; 1999. 
93.  Shelby M. NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methanol. 2003. U.S. Department of Health and Human Services; 2003. 
94.  Frezza M, di Padova C, Pozzato G, Terpin M, Baraona E, Lieber C. High blood alcohol levels in women. The role of decreased gastric alcohol dehydrogenase activity and first-pass metabolism. N Engl J Med. 1990;322(2):95-9. 
95.  Christenson L, Borrowman T, Vachon C, Tollefson M, Otley C, Weaver A, et al. Incidence of Basal Cell and Squamous Cell Carcinomas in a Population Younger Than 40 Years. JAMA 2005;294(6):681-90. 
96.  Mahalik M, Gautieri R. Reflex Responsiveness of CF-1 Mouse Neonates Following Maternal Aspartame Exposure. Res Commun in Psych 1984;9:385. 
97.  Dahl O, Aarseth J, Myhr K, Nyland H, Midgard R. Multiple sclerosis in Nord-Trondelag County. Norway. A prevalence and incidence study. Acta Neurol Scand 2003;109(6):378-84. 
98.  Fighting Autism. Number of Cases 2001. Available from: URL: 
99.  Gettler A, St.George A. Wood Alcohol Poisoning. Journal of the American Medical Association 1918;70:145. 
100.  Sturtevant F. Use of Aspartame in Pregnancy. Int J Fertil 1985;30(1):85. 
101.  Anonymous. Therapeutic claims in multiple sclerosis.: National Multiple Sclerosis Society; 1982. 
102.  Sturtevant F. Does Aspartame Cause Methanol Toxicity? Fd Chem Toxic 1985;23(10):961. 
103.  Infurna R, Weiss B. Neonatal Behavioral Toxicity in Rats Following Prenatal Exposure to Methanol. Teratology 33:259-265 1986;33:259-65. 
104.  Bolon B, Dorman D, Janszen D, Morgan K, Welsch F. Phase-specific developmental toxicity in mice following maternal methanol inhalation. Fundam Appl Toxicol 1993;21(4):508-16. 
105.  Dorman D, Bolon B, Struve M, LaPerle K, Wong B, Elswick B, et al. Role of formate in methanol-induced exencephaly in CD-1 mice. Teratology 2005;51(1):30-40. 
106.  Potts A, Praglin J, Farkas J, Orbison L, Chickering D. Studies on the Visual Toxicity of Methanol. VIII. Additional Observations on Methanol Poisoning in the Primate Test Object. Am J Ophthalmol. 1955;40(5 part 2):76-83. 
107.  Kavet R, Nauss K. The Toxicity of Inhaled Methanol Vapors. Critical Reviews in Toxicology 1090;21(1):21-50. 
108.  Rabinowitch I. Biochemical Studies in a Fatal Case of Methyl Alcohol poisoning. Archives of Internal Medicine Chicago 1922;29:821-27. 
109.  Kane R, Talbert W, Harlan J, Sizemore G, Cataland S. A methanol poisoning outbreak in Kentucky. A clinical epidemiological study. Arch Environm Hlth 1968;17:119. 
110.  Menne F. Acute Methyl Alcohol Poisoning. a Report of Twenty-Two Instances with Postmortem Examinations. Archives of Pathology. 26:77 1935;26:77-92. 
111.  Altman L. Two Win Nobel Prize for Discovering Bacterium Tied to Stomach Ailments. New York Times 2005;Sect. Science. 
112.  Kini M, Cooper J. Biochemistry of Methanol Poisoning-III; The Enzymic Pathway for the Conversion of Methanol to Formaldehyde. Biochemical Pharmacology 1961;8:207. 
113.  Kini M, Cooper J. Biochemistry of Methanol Poisoning; The Effect of Methanol and its Metabolites on Retinal Metabolism. Biochemical Journal 1962;82:164. 
114.  French D, Edsall J. The Reactions of Formaldehyde with Amino Acids and Proteins. Adv Protein Chem 1945;2:277-335. 
115.  Leaf G, Zatman L. A Study of the Conditions Under Which Methanol May Exert a Toxic Hazard in Industry. British Journal of Industrial Medicine 1952;9:19. 
116.  Cooper J, Kini M. Biochemical Aspects of methanol Poisoning. Biochemical Pharmacology 1962;11:405. 
117.  Cooper J, Felig P. The Biochemistry of Methanol Poisoning. II. Metabolic Acidosis in the Monkey. Toxicol.Appl.Pharmacol 1961;3:202. 
118.  Clay K, Murphy R, Watkins W. Experimental Methanol Toxicity in the Primate; Analysis of Metabolic Acidosis. Toxicol.Appl.Pharmacol 1975;34:49. 
119.  McLean D, Jacobs H, Mielke B. Methanol Poisoning A Clinical and Pathological Study. Annals of Neurology 1979;8:161. 
120.  Posner H. Posner HS. 1975. Biohazards of Methanol in Proposed New Uses. J Toxicol Environ Health 1975;1:153. 
121.  Tephly T, McMartin K. Methanol metabolism and toxicity. In: Stegink L, Filer L, editors. Aspartame: Physiology and Biochemistry. New York: Marcel Dekker Inc.; 1984. p. 111-40. 
122.  von Oettingen W. The Aliphatic Alcohols Their Toxicity and Potential Dangers in Relation to Their Chemical Constitution and Their Fate in Metabolism. Public Health Bulletin 1943;281:8. 
123.  Schink B, Zeikus J. Microbial Methanol Formation: A Major End product of pectin Metabolism. Current Microbiology 1980;4:387-89. 
124.  Nelson B, Brightwell W, MacKenzie D, Khan A, Burg J, Weigel W, et al. Teratological Assessment of Methanol and Ethanol at High Inhalation Levels in Rats. Fundam Appl Toxicol 1985;5:727. 
125.  Sollmann T. Studies of chronic intoxications on albino rats. II. Alcohol; Methyl. ethyl. “wood” and acetone. J Pharmacol Exper Therap 1920;16:291. 
126.  Victor M. Some Observations on the Neurological Effects of Alcohol Intoxication and Withdrawal. In: Roizin L, Shiraki H, Grcevic N, editors. Neurotoxicology. New York: Raven Press; 1977. p. 517-27. 
127.  Smith S, Smith S, Buckley B. Combined Formate and Lactate Acidosis in Methanol Poisoning. Lancet 1981;2(8258):1295-6. 
128.  Fulop M. Methanol Intoxication. Lancet 1982;1(8267):338. 
129.  Roe O. The Ganglion Cells of the Retina in Cases of Methanol Poisoning in Human Beings and Experimental Animals. Acta Opthalmologica 1948;26:169-82. 
130.  Potts A. The Aliphatic Alcohols, Chapter 15. In: Sears M, editor. “Pharmacology of the Eye” - Handbook of Experimental Pharmacology Vol. 69: XXV. Berlin, Heidelberg, New York, Tokyo: Springer-Verlag New York, LLC; 1984. p. 639-53. 
131.  Martin-Amat G, McMartin K, Hayreh S, Hayreh M, Tephly T. Methanol Poisoning Ocular Toxicity Produced by Formate. Toxicology and Applied Pharmacology 1978;45:201-8. 
132.  Makar A, Tephly T, Mannering G. Methanol Metabolism in the Monkey. Molecular Pharmacology 1968;4:471-83. 
133.  Majchrowicz E. Biochemical Pharmacology of Ethanol. New York: Plenum Press; 1973. 
134.  Majchrowicz E, Mendelson J. Blood Methanol Concentrations During Experimentally Induced Ethanol Intoxication in Alcoholics. The Journal of Pharmacology and Experimental Therapeutics 1971;179:293-300. 
135.  Magrinat G, Dolan J, Biddy R, Miller L, Korol B. Ethanol and Methanol Metabolites in Alcohol Withdrawal. Nature 1973;244:234-5. 
136.  Walder A, Redding J, Faillace L, Steenberg W. Rapid Detoxification of the Acute Alcoholic with Hemodialysis. Surgery 1969;66:201-7. 
137.  Guggenheim M, Couch J, Weinberg W. Motor Dysfunction as a Permanent Complication of Methanol Ingestion. Archives of Neurology 1971;24:550-4. 
138.  Scott E, Helz M, McCord C. The Histopathology of Methyl Alcohol Poisoning. American Journal of Clinical Pathology 1933;3:311-19. 
139.  Keyvan-Larijarni H, Tannenberg A. Methanol Intoxication; Comparison of Peritoneal Dialysis and Hemodialysis Treatment. Arch Intern Med 1974;134:293-6. 
140.  Gronning M, Albrektsen G, Kvale G, Moen B, Aarli J, Nyland H. Organic solvents and multiple sclerosis: a case-control study. Acta Neurol Scand 1993;88:247-50. 
141.  Agner K, Hook O, von Porat B. The Treatment of Methanol Poisoning with Ethanol. With Report of Two Cases. Quarterly Journal of Studies on Alcohol 1949;9:515-22. 
142.  Roe O. The roles of Alkaline salts and Ethyl Alcohol in the treatment of Methanol Poisoning. Quart.J.Stud.Alcohol 1950;11:107-12. 
143.  Erlanson P, Fritz H, Hagstam K, Liljenberg B, Tryding N, Voigt G. Severe Methanol Intoxication. Acta Medica Scandinavica 1965;177(4):393-408. 
144.  Browning E. Methanol Toxicology. In: Browning E, editor. Toxicity and Metabolism of Industrial Solvents. New York: Elsevier Publishing Company; 1965. p. 315-23. 
145.  Humphries P, Pretorius E, Naud H. Direct and indirect cellular effects of aspartame on the brain. Eur J Clin Nutr 2007;8:1-12. 
146.  Isaacs R. Acute Methyl Alcohol Poisoning. JAMA 1920;75:718-21. 
147.  Pick L, Bielschowsky M. Ueber histologische Befunde im Auge and im Zentralnervensystem des Menschen bei akuter todlicher Vergiftung mit Methylalkohol. Klin Wschr 1912;49:888-93. 
148.  Sharpe J, Hostovsky M, Bilbao J, Rewcastle N. Methanol optic neuropathy; A histopathological study. Neurology 1982;32:1093-100. 
149.  Waksman B, Reynolds W. Multiple Sclerosis as a Disease of Immune Regulation. Proceedings of the Society for Experimental Biology and Medicine 1984;175:282-94. 
150.  Pohl J. Ueber die Oxydation des Methyl Und Aethylalkohols im Thierkorper. Naunyn-Schmiedeberg’s Arch Exp Path Pharmak 1893;31:281-302. 
151.  Anderson C, Rubinstein D, Filley C, Stears J. MR enhancing brain lesions in methanol intoxication. J Comput Assist Tomogr 1997;21(5):834-6. 
152.  Fackelmann K. Myelin on the Mend: Can antibodies reverse the ravages of multiple sclerosis? Science News 1990;137:218-9. 
153.  Wolfgram F. What if Multiple Sclerosis isn’t an Immunological or Viral Disease? The Case for a Circulating Toxin. Neurochemical Research 1979;4:1-14. 
154.  Adams C. Histochemical Contributions to the Study of Multiple Sclerosis. In: Stoward P, Polak J, editors. Histochemistry: The Widening Horizons: John Wiley & Sons Ltd.; 1981. p. 163-81. 
155.  Giulisni G., Brizoli E., Angeleri VA., Caraffa 0., Foschih N., Speranzini C. The organic glue solvents in the pathogenesis of multiple sclerosis: anEpidemiological study. (Battaglia MA., Crimi G., eds. International Multiple Sclerosis Conference, Rome,Sept. 14-17,1988; 1988 Sep 14-17; Rome. An Update on Multiple Sclerosis (International Congress Series). 
156.  Brown M, Goldstein J. Lipoprotein Metabolism in the Macrophage; Implications for Cholesterol Deposition in Atherosclerosis. Annu Rev Biochem 1983;52:223-61. 
157.  Tephly T. Factors in Responses to the Environment. Introduction. Federation Proceedings 1977;36(5):1627. 
158.  Blundell J, Hill A. Paradoxical Effects of an Intense Sweetener (Aspartame) on Appetite. Lancet 1986;1:1092. 
159.  Coulombe R, Sharma R. Neurobiochemical Alterations Induced by the Artificial Sweetener Aspartame (NutraSweet). Toxicology and Applied Pharmacology 1986;83:79-85. 
160.  Walton R. Seizure and Mania After High Intake of Aspartame. Journal of the Academy of Psychosomatis Medicine 1986;27:218-20. 
161.  Roak-Foltz RI, Leveille G. Projected Aspartame Intake: Daily Ingestion of Aspartic Acid. Phenylalanine. and Methanol In AspartameAspartame. In: Stegink L, Filer L, editors. Aspartame: Physiology and Biochemistry. New York: Marcel Dekker; 1984. p. 201-5. 
162.  Main R, Barry M. On The Toxicity of Methyl Alcohol in Extracts and Medicine. Illinois Medical Journal 1903;69:153-58. 
163.  Koller C. Poisoning by Wood Alcohol: A case of Complete Blindness (Transitory) with Recovery of Vision. Medical Record 1905;68(1):10-2. 
164.  Stedman T. The Wood Alcohol Question. Medical Record 1905;67:59,102,381. 
165.  Wood C. Death and Blindness as a Result of Poisoning by Methyl Alcohol or Wood Alcohol and Its Various Preparations. International Clinics; A Quarterly of Clinical Lectures 1906;16:68. 
166.  Kritchevsky M. Multiple Sclerosis. In: Wigbert CW, MD., editor. Neurology for Non-Neurologists. Philadelphia: Grune & Stratton; 1988. p. 177-87. 
167.  Blaivas J. Evaluation of Urinary Bladder Symptoms in Multiple Sclerosis. In: Poser C, editor. The Diagnosis of Multiple Sclerosis. New York: Thieme - Stratton Inc.; 1984. 
168.  Kurtzke J. Epidemiologic contributions to multiple sclerosis; An overview. Neurology 1980;30(7):61-79. 
169.  Matthews B. Multiple Sclerosis: The Facts. New York Toronto: Oxford University Press; 1978. 
170.  Mawdsley C, Mayer R. Nerve Conduction in Alcoholic Polyneuropathy. Brain 1965;88:335-56. 
171.  Benton C, Calhoun F. The Ocular Effects of Methyl Alcohol Poisoning. Report of a Catastrophe involving Three Hundred and Twenty Persons. Trans Amer Acad Ophthal Otolaryng 1952;56:875-85. 
172.  Yano K, Rhoads G, Kagan A. Coffee. Alcohol and Risk of Coronary Heart Disease Among Japanese Men Living in Hawaii. NEJM 1977;297(8):405-9. 
173.  Lester D. Endogenous Ethanol: A Review. Quarterly Journal of Studies on Alcohol 1961;22:555-74. 
174.  Lester D. The Concentration of Apparent Endogenous Ethanol. Q J Stud Alcohol 1962;23:17. 
175.  Lieber C, DeCarli L. Hepatic Microsomal Ethanol-Oxidizing System. In vitro characteristics and adaptive properties in vivo. The Journal of Biological Chemistry 1970;245(10):2505-12. 
176.  Klatsky A, Friedman G, Siegelaub A. Alcohol and Mortality. Annals of Internal Medicine 1981;95:139-45. 
177.  Hoque M., Monte WC., Black L., Johnston CS. Methanol Neuropathy and Teratology A Histological Study on Long-Evans Rats. FASEB 1988;25(2(6)):A513. 
178.  Benditt E. The Origin of Atherosclerosis. Scientific American 1994;236(2):74-85. 
179.  Metz B, Kersten G, Jong A, Meiring H. Identification of formaldehyde-induced modifications in proteins: reactions with diphtheria toxin 2005. Available from: URL: 
180.  Christian T, Kleiss B, Yokelson R, Holzinger R, Crutzen P, Hao W, et al. Comprehensive laboratory measurements of biomass-burning emissions: 1. Emissions from Indonesian, African, and other fuels. J Geophys Re 2003;108(D23):4719-32. 
181.  Grey D. Summary of Adverse Reactions Attributed to Aspartame. US Department of Health and Human Services; 1995. 
182.  Criqui M, Wallace R, Heiss G, Mishkel M, Schonfeld G, Jones G. Cigarette smoking and plasma high-density lipoprotein cholesterol. The Lipid Research Clinics Program Prevalence Study. Circulation 1980;62(4 Pt 2):70-6. 
183.  Parthasarathy N, Kumar R, Manikandan S, Devi R. Methanol-Induced Oxidative Stress in Rat Lymphoid Organs. J Occup Health 2006;48:20-7. 
184.  Hawkes C. Is multiple sclerosis a sexually transmitted infection? Journal of Neurology Neurosurgery and Psychiatry 2002;73(4):439-43. 
185.  Kantarci O, Wingerchuk D. Epidemiology and natural history of multiple sclerosis: new insights. Curr Opin Neurol 2006;19:248-54. 
186.  Dahshan A, Donovan K. Auto-Brewery Syndrome in a Child With Short Gut Syndrome: Case Report and Review of the Literature. Journal of Pediatric Gastroenterology and Nutrition 2001;33:214-15. 
187.  Borras E, Coutelle C, Rosell A, Fernandez-muixi F, Broch M, Crosas B. Genetic Polymorphism of Alcohol Dehydrogenase in Europeans: The ADH2*2 Allele Decreases the Risk for Alcoholism and Is Associated With ADH3*1. Hepatology 2000;31(4):984-89. 
188.  Erickson S, Kulkarni AB. Methanol in Normal Human Breath. Science 1963;141:639-40. 
189.  Wood C, Buller F. Poisoning by Wood Alcohol: Cases of Death and Blindness from Columbian Spirits and other Nethylated Preparations. JAMA 1904;43:972-77, 1058-62,1117-23,1213-21,1289-95. 
190.  Kingsbury K. The Changing Face Of Breast Cancer. TIME 2007;107(16):36-40. 
191.  Gram I, Braaten T, Terry P, Sasco A. Breast Cancer Risk Among Women Who Start Smoking as Teenagers. Cancer Epidemiology Biomarkers & Prevention 2005;14(1):61-6. 
192.  Nagata C, Mizoue T, Tanaka K, Tsuji I. Tobacco Smoking and Breast Cancer Risk: An Evaluation Based on a Systematic Review of Epidemiological Evidence among the Japanese Population. Jpn J Clin Oncol 2006;36(6):387-94. 
193.  Kingsbury K. The Changing Face Of Breast Cancer. TIME Magazine 2007;107(16):36. 
194.  Monte W. A Deadly Experiment: MS & Aspartame Are They Linked? Fitness Life 2007;34:36-43. 
195.  Kurtzke J. Epidemiology and multiple sclerosis a personal review 2003. Available from: URL: 
196.  Godish T. Formaldehyde Exposures from Tobacco Smoke: A Review. American Journal of Public Health 1989;79(8):1044-45. 
197.  Bressler J. The Bressler Report. United States Food and Drug Administration; 1977. 
198.  Puchtler H, Meloan S. On the chemistry of formaldehyde fixation and its effect on immunohistochemical reactions. Histochemistry 1985;82:201-4. 
199.  Taskinen HK., Kyyronen P, Sallmen M, Virtanen S, Liukkonen T, Huida O. Reduced Fertility Among Female Wood Workers Exposed to Formaldehyde. American Journal of Industrial Medicine 1999;36:206-12. 
200.  Metz B., Kersten G, Hoogerhout P, Brugghe H, Timmermans H. Identification of Formaldehyde-induced Modifications in Proteins. The Journal of Biological Chemistry 2004;279(8):6235-43. 
201.  Hansen J, Contreras K, Harris C. Methanol. Formaldehyde. and Sodium Formate Exposure in Rat and Mouse Conceptuses: A Potential Role of the Visceral Yolk Sac in Embryotoxicity. Birth Defects Research (Part A) 2004;73:72-82. 
202.  Monte W. Bittersweet: Aspartame Breast Cancer Link. Fitness Life 2008;34:21-2. 
203.  Anonymous. Definition of Adenocarcinoma. 2001. Available from: URL: 
204.  Darwish A., Roth C, Duclos P, Ohnd S, Nassar A. Investigation into a cluster of infant deaths following immunization: evidence for methanol intoxication. Vaccine 20 2002;20:3585-89. 
205.  Shahangian S, Ash O. Formic and Lactic Acidosis in a Fatal Case of Methanol Intoxication. Clin Chem 1986;32(2):295-97. 
206.  Rogers J, Brannen K, Barbee B, Zucker R, Degitz S. Methanol Exposure During Gastrulation Causes Holoprosencephaly. Facial Dysgenesis. and Cervical Vertebral Malformations in C57BL/6J Mice. Birth Defects Research 2004;71:80-8. 
207.  Abbott B, Ebron-McCoy M, Andrews J. Cell death in rat and mouse embryos exposed to methanol in whole embryo culture. Toxicology 1994;97:159-71. 
208.  Arigeleri F., Bollettini 0., Brizoli E., Giuliani 0., Scarpino 0. A prevalence study of multiple sclerosis in the Regiorse Marchi, Italy. (Battaglia MA., Crimi G., eds. International Multiple Sclerosis Conference, Rome,Sept. 14-17,1988; 1988 Sep 14-17; Rome. 
209.  Henry T. Ditto-machine fluid harmful. Union charges. USA Today 1995 Mar 22;Sect. F:F-2. 
210.  Walsh S, DeChello L. Excess Autoimmune Disease Mortality Among School Teachers. Rheumatology 2001;28:1537-45. 
211.  Kruse J. Methanol poisoning. Intensive Care Med 1992;18:391-7. 
212.  d’Alessandro A, Osterloh J, Chuwers P, Quinlan P, Kelly T, Becker C. Formate in Serum and Urine after Controlled Methanol Exposure at the Threshold Limit Value. Environmental Health Perspectives 1994;102(2):178-81. 
213.  Bernstein L, Allen M, Anton-Culver H, Deapen D, Horn-Ross P. High breast cancer incidence rates among California teachers: results from the California Teachers Study (United States). Cancer Causes and Control 2002;13:625-35. 
214.  Redelings M, McCoy L, Sorvillo V. Multiple Sclerosis Mortality and Patterns of Comorbidity in the United States from 1990 to 2000. Neuroepidemiology 2006;26:102-07. 
215.  Becker C. Methanol Poisoning. Journal of Emergency Med 1983;1:51-8. 
216.  Crabb D, Matsumoto M, Chang D, You M. Overview of the role of alcohol dehydrogenase and aldehyde dehydrogenase and their variants in the genesis of alcohol-related pathology. Proceedings of the Nutrition Society 2004;63:49-63. 
217.  King A, Threlfall W, Band P, Gallagher R. Mortality Among Female Registered Nurses and School Teachers in British Columbia. American Journal of Industrial Medicine 1994;26:125-32. 
218.  Mori O, Haseba T, Kameyama K, Shimizu H. Histological distribution of class III alcohol dehydrogenase in human brain. Brain Research 2000;852:186-90. 
219.  Labreche F, Goldberg M. Exposure to Organic Solvents and Breast Cancer in Women: A Hypothesis. American Journal of Industrial Medicine 1997;32:1-14. 
220.  Allili-Hassani A, Martinez S, Peralba J. Alcohol dehydrogenase of human and rat blood vessels. FEBS Letters 1997;405:26-30. 
221.  Buehler R, Hess M, Wartburg J. Immunohistochemical Localization of Human Liver Alcohol Dehydrogenase in Liver Tissue. Cultured Fibroblasts. and HeLa Cells. American Association of Pathologists 1982;108(1):89-99. 
222.  Alemany M. Open Letter To Hawaii House Committee on Health. Maria Alemany Professor of Nutrition and Food Science University of Barcelona. Spain.; 2008 Feb 12. 
223.  Stegink L. Aspartame Metabolism in Humans: Acute Dosing Studies. In: Stegink L, Filer L, Tephly T, editors. Aspartame Physiology and Biochemistry. New York: Marcel Dekker; 1984. p. 509-54. 
224.  Kim J, Mastronardi F, Wood D, Lubman D, Zand R, Moscarello M. Multiple Sclerosis: An important role for post-translational modifications of myelin basic protein in pathogenesis. Molecular & Cellular Proteomics 2003;2(7):453-62. 
225.  Szende B, Tyihak E., Trez L. Role of arginine and its methylate derivatives in cancer biology and treatment. Cancer Cell International 2001;1(3):1-5. 
226.  Joiris N. Le Scotome central positif et Transitoire signe de weekers) dans la nevrte optique Retrobulbaire. au cours de L’intoxication aigue par l’alcool methylique. Arch Dophtalmolojie 1935;1:52. 
227.  Mumford P. Two Forms of Dermatitis Due to the Use of Methylated Spirit Externally. British Medical Journal 1925;2:607. 
228.  Novick N. Aspartame-Induced Granulomatous Panniculitis. Annals of Internal Medicine 1985;102(2):206-7. 
229.  Rao K, McConnell R, Waisman HA. 52 Week Oral Toxicity Study in the Infant Monkey (SC-18862). In: Searle Research and Development, editor. Docket File. Aspartame for use as a Sweetener in Carbonated Beverages.. Petition submitted to the United States Food and Drug Administration - FAP Part of 2A3661; 1972. 
230.  Kesselring J. Multiple Sclerosis.: Cambridge University Press; 1997. 
231.  Obeid R, Kasoha M, Knapp J, Kostopoulos P. Folate and Methylation Status in Relation to Phosphorulated Tau Protein and Amyloid in Cerebrospinal Fluid. 53(6):1129-1136. Clinical Chemistry 2007;53(6):1129-36. 
232.  Staehelin H. Micronutrients and Alzheimer’s disease. Proceedings of the Nutrition Society 2005;64:565-70. 
233.  Yang C, Otsuka M, Ohama E. An Immunohistochemical Study of Perivascular Plaque in Alzheimer’s Disease and Cerevral Amyloid Angiopathy. Yongo Acta Medica 2003;46:9-16. 
234.  Nie C, Wei Y, Chen X, Liu Y, Dui W, Liu Y, et al. Formaldehyde at Low Concentration Induces Protein Tau into Globular Amyloid-Like Aggregates In Vitro and In Vivo. PLoS ONE 2007;2(7:e629):1-13. 
235.  Nie C, Wang X, Liu Y, Perrett S, He R. Amyloid-like aggregates of neuronal tau induced by formaldehyde promote apoptosis of neuronal cells. BMC Neuroscience 2007;8(9):1-16. 
236.  Köppel C, Baudisch H, Schneider V, Ibe K. Suicidal ingestion of formalin with fatal complications. Intensive Care Med 1990;16(3):212-4. 
237.  Andersen K, Launer L, Dewey M, Letenneur L, Ott A, Copeland J. Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies. Neurology 1999;53(9):1992-7. 
238.  Palmisano J, Gruver C, Adams N. Absence of anion gap metabolic acidosis in severe methanol poisoning: a case report and review of the literature. Am J Kidney Dis 1987;9(5):441-4. 
239.  Hovda K, Munda lH, Urdal P., McMartin K, Jacobsen D. Extremely slow formate elimination in severe methanol poisoning: a fatal case report. Clin Toxicol (Phila) 2007;45(5):516-21. 
240.  Alemany M. Open Letter To The Public. Maria Alemany Professor of Nutrition and Food Science University of Barcelona. Spain.; 2008. 
241.  Zheng T, Holford T, Taylor Mayne S, Luo J. A case-control study of occupation and breast-cancer risk in Connecticut. J Cancer Epidemiol Prev 2002;7(1):3-11. 
242.  Stürmer T, Wang-Gohrke S, Arndt VB, H., Kong X, Kreienberg R, Brenner H. Interaction between alcohol dehydrogenase II gene, alcohol consumption, and risk for breast cancer. Br J Cancer 2002;87(5):519-23. 
243.  Mann K, Dengler W. Changes in the central nervous system of alcohol dependent patients. Research Society of Alcoholism 2005;29(5):896-901. 
244.  Naya M, Nakanishi J, Risk assessment of formaldehyde for the general population in Japan. Regul Toxicol Pharmacol 2005;43(3):232-48. 
245.  Amaducci L., Arfaoi0li C., Inzircari D., Marci M. Multiple sclerosis among shoe and leather workers: an epidemiological survey in Florence. Acta Neurol Scand 1982;65:94-103. 
246.  Kurtzke J. Epidemiologic evidence for multiple sclerosis as an infection. Clin Microbiol Rev 1993;6(4):382-427. 
247.  Monte WC. Aspartame News Articles and other stuff.; 2009. 
248.  Kurtzke J. Kurtzke JF. 2005. Epidemiology and etiology of multiple sclerosis. Phys Med Rehabil Clin N Am 2005;16(2):327-49. 
249.  Ong E, Glantz S. Tobacco industry efforts subverting International Agency for Research on Cancer’s second-hand smoke study. Lancet 2000;355:1253-9,1197-9. 
250.  Krieger N. Is breast cancer a disease of affluence. poverty. or both? The case of African American women. Am J Public Health 2002;92(4):611-13. 
251.  Kahn A, Blum D. Methyl alcohol poisoning in an 8-month-old boy: an unusual route of intoxication. J Pediatr 1979;94(5):841-3. 
252.  Anonymous. Spirit Duplicators. 2001. Available from: URL: 
253.  McCoy H, Cipolle R, Ehlers S, Sawchuk R, Zaske D. Severe Methanol Poisoning: Application of a Pharmacokinetic Model for Ethanol Therapy and Hemodialysis. Amer J Med 1979;67:604-7. 
254.  Roy M, Bailey B, Chalut D, Senécal P, Gaudreault P. What are the adverse effects of ethanol used as an antidote in the treatment of suspected methanol poisoning in children? 41(2):155-61. J Toxicol Clin Toxicol 2003;41(2):155-61. 
255.  Medinsky M, Dorman D. Recent developments in methanol toxicity. Toxicology Letters 1955;82(83):707-11. 
256.  Sakanashi T, Rogers J, Fu S, Connelly L, Keen C. Influence of maternal folate status on the developmental toxicity of methanol in the CD-1 mouse. Teratology 1996;54(4):198-206. 
257.  Thrasher J, Broughton A, Micevich P. Antibodies and immune profiles of individuals occupationally exposed to formaldehyde: six case reports. Am J Ind Med 1988;14(4):479-88. 
258.  Khoury S, Guttmann C, Orav E, Kikinis R, Jolesz F, Weiner H. Changes in Activated T Cells in the Blood Correlate With Disease Activity in Multiple Sclerosis. Archives of Neurology 2000;57:1183-89. 
259.  Makar A, Tephly T, Sahin G, Osweiler G. Formate metabolism in young swine. Toxicol Appl Pharmacol 1990;105(2):315-20. 
260.  Dorman D, Dye J, Nassise M, Ekuta J, Bolon B, Medinsky M. Acute Methanol Toxicity in Minipigs. Fundam Appl Toxicol 1993;20(3):341-7. 
261.  Tephly T, Green M, Gamble J. Formate metabolism in micropig. Toxicol Appl Pharmacol 1992;116(1):142-5. 
262.  Anonymous. The History of MS. 2001. Available from: URL: 
263.  Anonymous. Acting Positively: Strategic Implications of the Economic costs of Multiple Sclerosis in Australia 2005. Available from: URL: 
264.  Paasma R, Hovda K, Tikkerberi A, Jacobsen D. Methanol mass poisoning in Estonia: outbreak in 154 patients. Clin Toxicol (Phila) 2007;45(2):152-7. 
265.  Hernández M, Holanda M, Tejerina E, González C. Methanol poisoning and heparin: a dangerous couple? Am J Emerg Med 2004;22(7):620-21. 
266.  Finkelstein Y, Vardi J. Progressive parkinsonism in a young experimental physicist following long-term exposure to methanol. Neurotoxicology 2002;23:521-5. 
267.  Belson M, Morgan B. Methanol Toxicity in a Newborn. J Toxicol Clin Toxicol 2004;42(5):673-7. 
268.  Kaphalia B, Carr J, Ansari G. Increased endobiotic fatty acid methyl esters following exposure to methanol. Fundam Appl Toxicol 1995;28(2):264-73. 
269.  Verhelst D, Moulin P, Haufroid V, Wittebole X, Jadoul M, Hantson P. Acute renal injury following methanol poisoning: analysis of a case series. J Toxicol 2004;23(4):267-73. 
270.  Bessell-Browne R, Bynevelt M. Two cases of methanol poisoning: CT and MRI features. Australas Radiol 2007;51(2):175-8. 
271.  Salzman M. Methanol Neurotoxicity. Clin Toxicol (Phila) 2006;44(1):89-90. 
272.  Tephly T. The Toxicity of Methanol. Life Sciences 1991;48:1031-41. 
273.  Tephly T. Comments on the purported generation of formaldehyde and adduct formation from the sweetener aspartame. Life Sciences 1999;65(13):157-60. 
274.  McMartin K, Martin-Amat G, Noker P, Tephly T. Lack of a role for formaldehyde in methanol poisoning in the monkey. Biochem Pharmacol 1979;28(5):645-9. 
275.  Thun M, Peto R, Lopez A, Monaco J, Henley S, Heath C. Alcohol consumption and mortality among middle-aged and elderly U.S. adults. N Engl J Med 1997;337(24):1705-14. 
276.  Ernstgård L, Shibata E, Johanson G. Uptake and disposition of inhaled methanol vapor in humans. Toxicol Sci 2005;88(1):30-8. 
277.  Hamilton R. Final Diagnosis - Multiple Sclerosis. 2001. Available from: URL: Search Result http--path_upmc_edu-cases-case79-images-micro6_jpg 
278.  Bolon B, Welsch F, Morgan K. Methanol-induced neural tube defects in mice: pathogenesis during neurulation. Teratology 1994;49(6). 
279.  Kloner R, Rezkalla S. Kloner RA. Rezkalla SH. 2007. To drink or not to drink? That is the question. Circulation 2007;116(11):306-17. 
280.  Vliegenthart R, Oei H, van den Elzen A, van Rooij F, Hofman A, Oudkerk M, et al. Alcohol consumption and coronary calcification in a general population. Arch Intern Med 2004;164(21):2355-60. 
281.  Akechi T, Asaki M, Uchitomi Y, Tsugane S. Alcohol consumption and suicide among middle-aged men in Japan. Brit J of Psychiatry 2006;188:231-36. 
282.  Woodward M, Tunstall-Pedoe H. Alcohol consumption. diet. coronary risk factors. and prevalent coronary heart disease in men and women in the Scottish heart health study. J Epidemiol Community Health 1995;49(4):354-62. 
283.  Wei M, Gibbons L, Mitchell T, Kampert J, Blair S. Alcohol intake and incidence of type 2 diabetes in men. Diabetes Care 2000;23(1):16-21. 
284.  Vahtera J, Poikolainen K, Kivimäki M, Ala-Mursula L, Pentti J. Alcohol intake and sickness absence: a curvilinear relation. Am J Epidemiol 2002;156(10):969-76. 
285.  Turvey C, Schultz S, Klein D. Alcohol use and health outcomes in the oldest old. Subst Abuse Treat Prev Policy 2006;29(1):1-8. 
286.  Mukamal K, Chung H, Jenny N, Kuller L, Longstreth W, Mittleman M, et al. Alcohol use and risk of ischemic stroke among older adults: the cardiovascular health study. Stroke 2005;36(9):1835-6. 
287.  McMartin K, Martin-Amat G, Tephly T. The Monkey as a Model in Methanol Poisoning. In: Thurman R, editor. Alcohol and Aldehyde Metabolizing Systems.Volume II Enzymology and Subcellular Organelles. San Diego, CA: Academic Press; 1977. p. 419-28. 
288.  Lang I, Wallace R, Huppert F, Melzer D. Moderate alcohol consumption in older adults is associated with better cognition and well-being than abstinence. Age Ageing 2007;36(3):256-61. 
289.  Koppes L, Dekker J, Hendriks H, Bouter L, Heine R. Moderate alcohol consumption lowers the risk of type 2 diabetes: a meta-analysis of prospective observational studies. Diabetes Care 2005;28(3):719-25. 
290.  Schwarzmann A. Methylalkoholvergiftung, chronische, durch Einatmen von Methyl-alkohol-haltigen Formaldehyddarnpfen, Samml. Vergiftungsf. 1934;5(129):A 442-61. 
291.  Medinsky M, Dorman D. Recent developments in methanol toxicity. Toxicology Letters 1995;82-83:707-11. 
292.  Brenner H, Arndt V, Rothenbacher D, Schuberth S, Fraisse E, Fliedner T. The association between alcohol consumption and all-cause mortality in a cohort of male employees in the German construction industry. Int J Epidemiol 1997;26(1):85-91. 
293.  Pedersen J, Heitmann B, Schnohr P, Grønbaek M. The combined influence of leisure-time physical activity and weekly alcohol intake on fatal ischaemic heart disease and all-cause mortality. Eur Heart J 2008;29(2):204-12. 
294.  Hougaku H, Fleg J, Lakatta E, Scuteri A, Earley C, Najjar S, et al. Effect of light-to-moderate alcohol consumption on age-associated arterial stiffening. Am J Cardiol 2005;95(8):1006-10. 
295.  Mukamal K, Robbins J, Cauley J, Kern L, Siscovick D. Alcohol consumption. bone density. and hip fracture among older adults: the cardiovascular health study. Osteoporos Int 2007;18(5):593-602. 
296.  Thomsen J. Atherosclerosis in alcoholics. Forensic Sci Int 1995;75(2-3):121-31. 
297.  Beulens J, Kruidhof J, Grobbee D, Chaturvedi N, Fuller J, Soedamah-Muthu S. Alcohol consumption and risk of microvascular complications in type 1 diabetes patients: the EURODIAB Prospective Complications Study. Diabetologia 2008;51(9):1631-8. 
298.  Duffy J. Alcohol consumption and all-cause mortality. Int J Epidemiol 1995;24(1):100-5. 
299.  Marmot M, Rose G, Shipley M, Thomas B. Alcohol and mortality: a U-shaped curve. Lancet 1981;1(8220 Pt1):580-83. 
300.  Mänttäri M, Tenkanen L, Alikoski T, Manninen V. Alcohol and coronary heart disease: the roles of HDL-cholesterol and smoking. J Intern Med 1997;241(2):157-63. 
301.  Rouillier P, Boutron-Ruault M, Bertrais S, Arnault N, Daudin J, Bacro J, et al. Alcohol and atherosclerotic vascular disease risk factors in French men: relationships are linear, J-shaped, and U-shaped. Alcohol Clin Exp Res 2005;29(1):84-8. 
302.  Wang J, Tung T, Yin W, Huang C, Jen H, Wei J, et al. Effects of moderate alcohol consumption on inflammatory biomarkers. Acta Cardiol 2008;63(1):65-72. 
303.  Kikuchi S, Nakajima T, Kobayashi O, Yamazaki T, Kikuichi M, Mori K. U-shaped effect of drinking and linear effect of smoking on risk for stomach cancer in Japan. Jpn J Cancer Res 2002;93(9):953-59. 
304.  Vanheusden K, van Lenthe F, Mulder C, van der Ende J, van de Mheen D. Patterns of association between alcohol consumption and internalizing and externalizing problems in young adults. J Stud Alcohol Drugs 69(1):49-57 2008;69(1):49-57. 
305.  Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, et al. McAlpine’s Multiple Sclerosis. Fourth Edition. 4 ed. London: Churchill Livingston - Elsevier.; 2005. 
306.  Murray T. Multiple Sclerosis - The History of a disease. New York: Demos Medical Publishing; 2005. 
307.  McAlpine D, Lumsden C. Multiple Sclerosis: A Reappraisal. Edinburgh London: E. & S. Livingston; 1968. 
308.  Shephard S. Pickled, Potted, and Canned. New York: Simon & Shuster Paperbacks; 2000. 
309.  Klaassen C. Casarett & Doull’s Toxicology The Basic Science of Poisons. 6 ed. New York: McGraw-Hill; 2001. 
310.  Wilson C, Trotter C. Scottish Heritage Food and Cooking. London: Lorenz Books; 2005. 
311.  Wolfgram F, Ellison G, Stevens J, Andrews J. Multiple Sclerosis - Immunology, Virology and Ultrastructure. New York: Academic Press; 1972. 
312.  Anonymous. The Canned Food Reference Manual 1939-942-1947. New York: American Can Company; 1950. 
313.  Anonymous. New Zealand Briefing on Aspartame.; 2008. 
314.  Anonymous. A History of the Canning and Freezing industry in New York State - 75th Anniversary. The New York State Canners and Freezers Association; 1960. 
315.  Bitting A. Appertizing - The Art of Canning Its History and Development.: The Trade Pressroom; 1937. 
316.  Burks J, Johnson K. Multiple Sclerosis - Diagnosis, Medical Management and Rehabilitation. New York: Demos; 2000. 
317.  Hayes A. Hayes AW. 1982. Principles and Methods of Toxicology. Raven Press. ISBN 0-89004-470-8. New York: Raven Press; 1982. 
318.  Hoshing S. The Canning industry of Japan. Tokyo: The Foreign Relations Council The Japan Economic Federation; 1940. 
319.  Beniac D, Wood D, Palaniyar N, Ottensmeyer F, Moscarello M, Harauz G. Marburg’s variant of multiple sclerosis correlates with a less compact structure of myelin basic protein. Mol Cell Biol Res Commun 1999;1(1):48-51. 
320.  Anonymous. The ABC’s of Canned Foods. New York: National Canners Association; 1955. 
321.  Oguma K, Lee J. Authors’ Reply. Microbiology 2006;152:1895-97. 
322.  Atassi M. On the enhancement of anti-neurotoxin antibody production by subcomponents HA1 and HA3b of Clostridium botulinum type B 16S toxin-haemagglutinin. Microbiology 2006;152:1891-95. 
323.  Weinshenker B. Therapeutic Plasma Exchange for Acute Inflammatory Demyelinating Syndromes of the Central Nervous System. Journal of Clinical Apheresis 1999;14:144-48. 
324.  Linseisen J, Rohrmann S, Norat T, Gonzalez C. Dietary intake of different types and characteristics of processed meat which might be associated with cancer risk--results from the 24-hour diet recalls in the European Prospective Investigation into Cancer and Nutrition (EPIC). Public Health Nutr 9(4):449-64 2005;9(4):449-64. 
325.  Anonymous. US Department of Vital Statistics/Center for Disease Control Leading causes of Death 1900 - 1998.; 2000. 
326.  Chen J, Haley R, Hidestrand M, Shankar K. Estradiol Protects Against Ethanol-Induced Bone Loss by Inhibiting Up Regulation of RANKL in Osteoblasts. 2006. Available from: URL: JPET Fast Forward DOI:10.1124/jpet.106.109454 JPET #109454 
327.  Beisswenger T, Holmquist B, Vallee B. Chi-ADH is the sole alcohol dehydrogenase isozyme of mammalian brains: implications and inferences. Proc Natl Acad Sci 1985;82(24):8369-73. 
328.  Jacob SE., Stechschulte S. Formaldehyde, aspartame, and migraines: a possible connection. Dermatitis 2008;19(3):E10-11. 
329.  Olney J, Farber N, Spitznagel E, Robins L. Increasing brain tumor rates: is there a link to aspertame. J Neuropathol Exp Neurol 1996;11:1115-23. 
330.  Launer L, Andersen K, Dewey M. Rates and risk factors for dementia and Alzheimer’s disease. Neurology 52: 78-84 1999;52:78-84. 
331.  Brey RL. Cigarette smoking and MS: Yet another reason to quit. Neurology 2003;61(8):E11-2. 
332.  Costenbader K, Karlson E. Cigarette smoking and autoimmune disease: what can we learn from epidemiology? Lupus 2006;15(11):737-45. 
333.  Riise T, Nortvedt M, Ascherio A. Smoking is a risk factor for multiple sclerosis. Neurology 2003;61(8):1122-24. 
334.  Behrend RC. Multiple sclerosis in Europe. Eur Neurol 1969;2(3):129-45. 
335.  Ogawa G, Mochizuki H, Kanzaki M, Kaida K, Motoyoshi K, Kamakura K. Seasonal variation of multiple sclerosis exacerbations in Japan. Neurol Sci 2003;24:417-19. 
336.  Abella-Corral J, Prieto J, Dapena-Bolaño D, Iglesias-Gÿ3mez S, Noya-García M, Lema M. Seasonal variations in the outbreaks in patients with multiple sclerosis. Rev Neurol 2005;40(7):394-96. 
337.  Celius E, Vandvik B. Multiple sclerosis in Oslo. Norway: prevalence on 1 January 1995. and incidence over a 25-year period. European Journal of Neurology 2001;8(5):463-74. 
338.  Barnett M, Williams D, Day S, Macaskill P, McLeod J. Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle. Australia: a 35-year study. J Neurol Sci 2003;213:1-6. 
339.  Sumelahti M, Tienari P, Wikström J, Palo J, Hakama M. Increasing prevalence of multiple sclerosis in Finland. Acta Neurol Scand 2001;103(3):153-58. 
340.  Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Pirastru M, Murgia B, et al. Multiple sclerosis epidemiology in Sardinia: evidence for a true increasing risk. Acta Neurol Scand. 2001;103(1):20-6. 
341.  Sundström P, Nyström L, Forsgren L. Incidence (1988-97) and prevalence (1997) of multiple sclerosis in Västerbotten County in northern Sweden. J Neurol Neurosurg Psychiatry 2003;74(1):29-32. 
342.  Pugliatti M, Riise T, Sotgiu M, Sotgiu S, Satta W, Mannu L, et al. Increasing incidence of multiple sclerosis in the province of Sassari. northern Sardinia. Neuroepidemiology 2005;25(3):129-32. 
343.  Pozzilli C, Romano S, Cannoni S. Epidemiology and current treatment of multiple sclerosis in Europe today. J Rehabil Res Dev 2002;39(2):175-85. 
344.  Pugliatti M, Sotgiu S, Rosati G. The worldwide prevalence of multiple sclerosis. Clin Neurol Neurosurg 2002;104(3):182-91. 
345.  Wald N, Hackshaw A. Cigarette smoking: an epidemiological overview. Brit. Med. Bull 1996;52(1):3-11. 
346.  Ranzato F, Perini P, Tzintzeva E, Tiberio M. Increasing frequency of multiple sclerosis in Padova. Italy: a 30 year epidemiological survey. Mult Scler 2003;9(4):387-92. 
347.  Netter F. The CIBA Collection of Medical Illustrations. Summit New Jersey: CIBA Pharmaceutical Company; 1962. 
348.  Granieri E, Casetta I, Govoni V, Tola M, Marchi D, Murgia S, et al. The increasing incidence and prevalence of MS in a Sardinian province. Neurology 2000;55:842-47. 
349.  Grimaldi L, Salemi G, Grimaldi G, Rizzo A, Marziolo R, Lo Presti C., et al. High incidence and increasing prevalence of MS in Enna (Sicily). southern Italy. Neurology 2001;57(10):1891-3. 
350.  Tanaka K, Kujuro Y, Suzuki S, Tanahashi N, Hamada J, Nogawa S, et al. Clinical and laboratory features of in-patients with multiple sclerosis in a University Hospital in Tokyo from 1988-2002. Intern Med 2005;44(6):560-66. 
351.  Alonso A, Hernán M. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 2008;71:129-35. 
352.  Hernán M, Olek M, Ascherio A. Geographic variation of MS incidence in two prospective studies of US women. Neurology 1999;53:1711-18. 
353.  Noonan C, Kathman S, White M. Prevalence estimates for MS in the United States and evidence of an increasing trend for women. Neurology 2002;51(1):136-38. 
354.  Rosati G. The prevalence of multiple sclerosis in the world: an update. Neurol Sci 2001;22:117-39. 
355.  Pugliatti M, Sotgiu S, Solinas G, Castiglia P, Rosati G. Multiple sclerosis prevalence among Sardinians: further evidence against the latitude gradient theory. Neurol Sci 2001;22(2):163-65. 
356.  Centers for Disease Control and Prevention (CDC). Update: trends in fetal alcohol syndrome--United States, 1979-1993. MMWR Morb Mortal Wkly Rep 1995;44(13):249-51. 
357.  Coutelle C. Risk Factors in Alcohol Associated Breast Cancer: Alcohol Dehydrogenase Polymorphism and Estrogens. International Journal of Oncology 2004;25:1127-32. 
358.  Triano E, Slusher L, Atkins T, Beneski J, Gestl S. Class I Alcohol Dehydrogenase Is Highly Expressed in Normal Human Mammary Epithelium but not in Invasive Breast Cancer: Implications for Breast Carcinogenesis. Cancer Research Arch 2003;63:3092-100. 
359.  Poschl G, Seitz H. Alcohol and Cancer (Review). Alcohol & Alcoholism 2004;39(3):155-65. 
360.  McAlpine D, Lumsden C. Multiple Sclerosis: A Reappraisal. Second Edition. 2 ed. London: Churchill Livingston; 1972. 
361.  McAlpine D, Compston N, Lumsden C. Multiple Sclerosis. First Edition. 1 ed. London: E. & S. Livingston; 1955. 
362.  Kirchner J, Miller J, Rice R, Keller G, Fox M. Volatile Water-Soluble Constituents of Grapefruit Juice. Journal of Agricultural and Food Chemistry 1953;1(7):510-11. 
363.  Turner C, Spanel P, Smith D. A longitudinal study of ethanol and acetaldehyde in the exhaled breath of healthy volunteers using selected-ion flow-tube mass spectrometry. Rapid Commun Mass Spectrom 2006;20:61-8. 
364.  Joshi R, Jan S, Wu Y, MacMahon S. Global Inequalities in Acess to Cardiovascular Health Care - Our Greatest Challenge. Journal of the American College of Cardiology 2008;52(23):1817-25. 
365.  Irving GW. Evaluation of the Health Aspects of Formic Acid, Sodium Formate, and Ethyl Formate as Food Ingredients. Bethesda Md: Federation of American Societies for Experimental Biology; 1974 No.: NTIS Doc PB-266 282, 1976. (NTIS Doc PB-266 282, 1976). 
366.  Chang M, Olin K, Tsoi C, Wight T, Chait A. Human monocyte-derived macrophages secrete two forms of proteoglycan-macrophage colony-stimulating Factor That Differ in their Ability to Bind Low Density Lipoproteins. J Biol Chem 1998;273(26):15985-92. 
367.  Yant W, Schrenk H. Distribution of methanol in dogs after inhalation and administration by stomach tube and subcutaneously. J Ind Hyg Toxicol 1937;19:337-45. 
368.  Wurtman R. Aspartame; Possible Effect on Seizure Susceptibility. Lancet 1985;2:8463:1060. 
369.  Wood D, Moscarello M. Is the Myelin Membrane Abnormal in Multiple Sclerosis? Journal of Membrane Biology 1984;79:195-201. 
370.  Tephly T, Parks R, Mannering G. Methanol Metabolism in the Rat. Journal of Pharmacology and Experimental Therapeutics 1964;143:292-300. 
371.  Walrath J, Fraumeni J. Proportionate Mortality among New York Embalmers. In: Gibson J, editor. Formaldehyde Toxicity. Washington: Hemisphere Publishing Corporation; 1994. p. 227-36. 
372.  Wallace R, Lynch C, Pomrehn P. Alcohol and Hypertension; Epidemiologic and Experimental Considerations. The Lipid Research Clinics Program. Circulation 64:III41 1981;64(suppl. III):41-7. 
373.  Von Wartburg JP, Buehler R. Biology of Disease - Alcoholism and Aldehydism: New Biomedical Concepts. Laboratory Investigation 1984;50(1):5-15. 
374.  Trumper M. The Antifreeze Methanol Hazard. International Clinics; A Quarterly of Clinical Lectures 1931(March):84-8. 
375.  Swenberg J, Gross E, Martin J, Popp J1M. Mechanisms of Formaldehyde Toxicity. In: Gibson J, editor. Formaldehyde Toxicity. Washington: Hemisphere Publishing Corp; 1983. p. 132-47. 
376.  Battey L, Patterson J, Heyman A. Effects of Methyl Alcohol on Cerebral Blood Flow and Metabolism Observations During and after Acute Intoxication. A.M.A.Archives of Neurology and Psychiatry 1956;23:252-56. 
377.  Sturtevant F. Aspartame--A New Food Ingredient Reply to the Critical Comments of Woodrow C. Monte. J.Environ.Sci.Health 1985;20(8):863. 
378.  Johnson R, Richardson E. The Neurological Manifestations of Systemic Lupus Erythematosus. Medicine. 1968;47(4):337-69. 
379.  Anonymous. Methanol Health Effects. 4100 North Fairfax Drive, Suite 740, Arlington, VA 22203: Methanol Institute; 2008. 
380.  Pearsall N, Weiser R. The Macrophage. Philadelphia: Lea and Febiger Publishing Corp.; 1970. 
381.  Jornvall H, Hempel J, von Bahr-Lindstrom H, Vallee B. Alcohol and Aldehyde Dehydrogenases Structures of the Human Liver Enzymes, Functional Properties and Evolutionary Aspects. Alcohol & Alcoholism 1987(Suppl.1):13-23. 
382.  Makar A, Mannering G. Role of Intracellular Distribution of Hepatic Catalase in the Peroxidative Oxidation of Methanol. Molecular Pharmacology 1968;4:484-91. 
383.  Majchrowicz E. Metabolic Correlates of Ethanol. In: Majchrowicz E, editor. Biochemistry and Pharmacology of Ethanol Volume 2. New York: Plenum Press; 1973. p. 122-40. 
384.  Majchrowicz E. Reversal in central nervous system function during ethanol withdrawal in humans and experimental animals. Federation Proceedings 1981;40(7):2065-40. 
385.  Smith C. Pathophysiology of the Alcohol Withdrawl Syndrome. Med Hypothesis. 7:231 1981;7:231-49. 
386.  Jacob M, Sellers E. Emergency Management of Alcohol Withdrawal. Drug Therapy Hospital. 1977;7(April):26-32. 
387.  Liskow B, Rinck C, Campbell J, DeSouza C. Alcohol Withdrawl in the Elderly. Journal of Studies on Alcohol. 50:414 1989;50(5):414-21. 
388.  Cohen G, Collins M. Alkaloids from Catecholamines in Adrenal Tissue Possible Role in Alcoholism. Science. Science 1970;167:1749-51. 
389.  Jones A. Elimination Half-life of Methanol During Hangover. Pharmacology & Toxicology 1987;60:217-20. 
390.  Lieber C, Seitz H, Garro A. Alcohol-Related Diseases and Carcinogensis. Cancer Research 1979;39:2863-86. 
391.  Ostrovsky Y, Pronko P, Shishkin S, Kolesnikov V, Volynets S. An Attempt to Evaluate Diagnostic and Prognostic Significance of Blood Endogenous Ethanol in Alcoholics and Their Relatives. Alcohol. 6:97 1989;6:97-102. 
392.  Breeden J. Alcohol, Alcoholism, and Cancer. Medical Clinics of North America 1984;68(1):163-77. 
393.  Smythies J. The Transmethylation and One-Carbon Cycle Hypotheses of Schizophrenia. Psychological Medicine 1983;13:711-14. 
394.  Davis V, Walsh M. Alcohol, Amines, and Alkaloids A Possible Biochemical Basis for Alcohol Addiction. Science 1970;167:1005-7. 
395.  Collins M, Cohen G. Isoquinoline Alkaloid Biosynthesis from Adrenal Catecholamines during C14 Methyl Alcohol Metabolism in Rats. Federation Proceedings 1970;29:608. 
396.  Ismail L, Sargent T, Dobson E, Pollycove M. Altered Metabolism of the Methionine Methyl Group in the Leukocytes of Patients with Schizophrenia. Biological Psychiatry 1978;13(6):649-59. 
397.  Cohen G, Barrett R. Fluorescence Microscopy of Catecholamine-Derived Tetrahydroisoquinoline Alkaloids Formed During Methanol Intoxication. Federation Proceedings 1969;28:288. 
398.  Cohen G. Alkaloid Products in the Metabolism of Alcohol and Biogenic Amines. Biochemical Pharmacology 1976;25:1123-28. 
399.  Price J. Methylation in Schizophrenics: A Pharmacogenetic Study. Journal of Psychiatry Research 1972;9:345-51. 
400.  Koivusalo M. Methanol. In: Tremolieres J, editor. Alcohols and Derivatives, vol 2. London: Pergamon Press; 1970. p. 465-505. 
401.  Gosselin R. Ethyl Alcohol/Ethylene Glycol/Methyl Alcohol. In: Gosselin R, editor. Clinical Toxicology of Commercial Products. Baltimore, Maryland: Williams & Wilkins; 1981. p. 229-33. 
402.  Eells J, McMartin K, Black K, Viravan V, Tisdell R, Tephly T. Formaldehyde Poisoning; Rapid Metabolism to Formic Acid. JAMA 1981;246(11):1237-37. 
403.  Kendal L, Ramanathan A. Excretion of Formate After Methanol Ingestion in Man. Biochemical Journal 1953;54:424-26. 
404.  Kini M, Cooper J. The Biochemistry of Methanol Poisoning I. Phosphorylation Coupled to the Mitochondrial Oxidation of Formaldehyde. Biochim Biophys Acta 1960;44:599-601. 
405.  Lope V., Pollán M., Gustavsson P, Plato N., et. al. Occupation and thyroid cancer risk in Sweden. J Occup Environ Med. 2005 Sep;47(9):948-57. 2005;47(9):948-57. 
406.  see 108. See 108. 
407.  Mannering GP, RE.Tephly, TR. Comments of a Recent Publication by Kini and Cooper which Purports to Show that Alcohol Dehydrogenase is Responsible for the Physiological Oxidation of Methanol. Biochem. Pharmacol 1962;11:677-79. 
408.  Miller T, Wolin M. Oxidation of Hydrogen and Reduction of Methanol to Methane is the Sole Energy Source for a Methanogen Isolated from Human Feces. Journal of Bacteriology 1983;153(2):1051. 
409.  Lester D, Greenberg L. The Inhalation of Ethyl Alcohol by Man. Quarterly Journal of Studies on Alcohol 1951;12:167-78. 
410.  Myddleton G1. Tobacco and Mortality. Lancet 1985;2:1430-31. 
411.  McAllister R. Exposure to Methanol from Spirit Duplicating Machines. American Industrial Hygiene Association Quarterly 1954;15:26-8. 
412.  Mendelson J, Wexler D, Leiderman P, Solomon P. A Study of Addiction to Nonethyl Alcohols and Other Poisonous Compounds. Quarterly Journal of Studies on Alcoholism 1957;18:561-80. 
413.  Krolman G, Pidde W. Acute Methyl Alcohol Poisoning. Canadian Journal of Ophthalmology 1968;3:270-78. 
414.  Krishnamurthi M, Natarajan A, Shanmugasundaram K, Fadmanabhan K, Nityanandan K. Acute Methyl Alcohol Poisoning. The Journal of the Association of Physicians of India 1968;16:801-05. 
415.  Keeney A, Mellinkoff S. Methyl alcohol poisoning. Ann Intern Med 1951;34:331-38. 
416.  Jacobson B, Russell H, Grimm J, Fox E. Acute Methyl Alcohol Poisoning: Report of Eighteen Cases. Naval Medical Bulletin 1945;44(1):1099-106. 
417.  Martensson E, Olofsson A. Clinical and Metabolic Features of Ethanol-Methanol Poisoning in Chronic Alcoholics. Lancet 1988;1:327-28. 
418.  Branch A, Tonning D. Acute methyl alcohol poisoning. Observations in some thirty cases. Canad J Publ Hlth 1945;36:147-51. 
419.  see 132. See 132. 
420.  McMartin K, Makar A, Martin-Amat G, Palese M, Tephly T. Methanol Poisoning. I. The Role of Formic Acid in the Development of Metabolic Acidosis in the Monkey and the Reversal by 4-Methylpyrazole. Biochemical Medicine 1975;13:319-33. 
421.  McMartin K, Martin-Amat G, Makar A, Tephly T. Methanol Poisoning. V. Role of Formate Metabolism in the Monkey. Journal of Pharmacology and Experimental Therapeutics 1977;201(3):564-72. 
422.  Baumbach G, Cancilla P, Martin-Amat G, Tephly T, McMartin K, Makar A, et al. Methyl Alcohol Poisoning. IV. Alterations of the Morphological Findings of the Retina and Optic Nerve. Arch Ophthalmol 1977;95:1859-65. 
423.  Makar A, Tephly T. Folate Deficiency and Methanol Poisoning In the Rat. In: Thurman R, editor. Alcohol and Aldehyde Metabolizing Systems.Volume II Enzymology and Subcellular Organelles. San Diego, CA: Academic Press. Inc.; 1977. p. 413-18. 
424.  Nachevski V. Testing of Some Plum Varieties Suitable for Industrial Use. Lozar Vinar 1980;29(4):19. 
425.  Self R, Casey J, Swain T. The Low-Boiling Volatiles of Cooked Foods. Chemistry and Industry 1963(May 25):863-64. 
426.  Manning D. Cheddar Cheese Flavour Studies. I. Production of Volatiles and Development of Flavour During Ripening. Journal of Dairy Research 1978;45(3):479-90. 
427.  Norman S, Craft C. Production of Ethanol. Acetaldehyde. and Methanol by Intact Oranges During and After Nitrogen Storage. Journal of the American Society for Horticulutral Science 1971;96(4):464-67. 
428.  Bigelow W, Cathcart P. Relation of Processing to the Acidity of Canned Foods. In: Goldblith S, Joslyn M, Nickerson J, editors. An Anthology of Food Science. Volume I - An Introduction to Thermal Processing of Foods. Berkeley, CA: AVI Publishing Co.; 1961. p. 579-600. 
429.  Anonymous. Treatment of Multiple Sclerosis. and also Methanol Poisoning. Lancet 1983(Apr 23):909-10. 
430.  Johnson K. Cerebrospinal fluid and blood assays of diagnostic usefulness in multiple sclerosis. Official Journal of the American Academy of Neurology. Neurology 1980;30(2):106-9. 
431.  Kinnunen E. Multiple Sclerosis in Finland; Evidence of Increasing Frequency and Uneven Geographic Distribution. Neurology 1984;34:457-61. 
432.  Larsen J, Aarli J, Nyland H, Riise T. Western Norway. a high-risk area for multiple sclerosis; A prevalence incidence study in the county of Hordaland. Neurology 1984;34:1202-7. 
433.  Paty D, Poser C. Clinical Symptoms and Signs of Multiple Sclerosis. In: Poser C, editor. The Diagnosis. Multiple Sclerosis.A Guide for Patients and Their Families. New York: Thieme-Stratton Inc.; 1984. p. 23-43. 
434.  McFarlin D, McFarland H. Medical Progress - Multiple Sclerosis. Part I. New England Journal of Medicine 1982;307(19):1183-88. 
435.  Kurtzke J. Epidemiological Findings Indicating An Exogenous Cause of MS. In: Boese A, editor. Search for the Cause of Multiple Sclerosis and Other Chronic Diseases of the Central Nervous System. Weinheim-Deerfield Beach. Florida-Basel: Verlag Chemie; 1979. 
436.  Kuroiwa Y. Does Asian MS Favor an Exogenous Agent as the Cause? In: Boese A, editor. Search for the Cause of Multiple Sclerosis and other Chronic Diseases of the Central Nervous System.Florida-Basel. Weinheim-Deerfield Beach-Florida-Basel.: Verlag Chemie; 1979. p. 405-13. 
437.  Chatard H, Gimbert E. Methanol dermatitis: Some reflections on its clinical and medico-legal aspects. Archives Des Maladies Professionnelles De Medicine Du Travail Et Securite Sociale 1951;12:436-38. 
438.  Dean J, Murray M, Ward E. Toxic Responses of the Immune System. In: Casarett and Doull’s Toxicology; The Basic Science of Poisons. New York: Macmallan Publishing Inc.; 1994. p. 245-85. 
439.  Zatman L. The Effect of Ethanol on the Metabolism of Methanol in Man. Biochem J 1946;40:67. 
440.  see 141. See 141. 
441.  Keeser E. Toxicity. Etiology and Therapeutic Control of Specific Toxicity of Methanol. Archive Fur Exper Pathund Pharmakol 1931;160:687-91. 
442.  Pohl J. About the oxidation of methyl and ethyl alcohol within the animal body. Naunyn-Schmiedeberg’s Arch Exp Path Pharmak 1893;31:281-302. 
443.  Orthner H. Methyl Alcohol Poisoning With Marked Cerebral Changes: Pathology of Cerebral Permeability. Virchows Archiv 1953;323:442-64. 
444.  Diefenbach W. Methyl Alcohol Poisoning: Diagnosis and Treatment. Mississippi Valley Medical Journal 1953;75:129-31,159-60. 
445.  Patterson R, Pateras V., Grammer LC., Harris KE. Human Antibodies Against Formaldehyde-Human Serum Albumin Conjugates or Human Serum Albumin in Individuals Exposed to Formaldehyde. Int Archs Allergy Appl Immunol 1986;79:53-9. 
446.  Newell G. Overview of Formaldehyde. In: Gibson J, editor. Formaldehyde Toxicity. Washington DC: Hemisphere Publishing Corporation; 1994. p. 3-35. 
447.  Heslinga F, Deierkauf F. The Action of Formaldehyde Solutions on Human Brain Lipids. Journal of Histochemistry and Cytochemistry 1962;10:704-9. 
448.  Kline B. Formaldehyde Poisoning: With report of a fatal case. Archives of Internal Medicine 1925;36:220-28. 
449.  Grafstrom R, Fornace A, Autrup H, Lechner J, Harris C. Formaldehyde Damage to DNA and Inhibition of DNA Repair in Human Bronchial Cells. Science 1983;220:216-18. 
450.  Gottschling L, Beaulieu H, Melvin W. Monitoring of Formic Acid in Urine of Humans Exposed to Low Levels of Formaldehyde. American Industrial Hygiene Association Journal 1984;45(1):19-23. 
451.  Marshall E. EPA Indicts Formaldehyde. 7 Years Later. Science 1987(April 24):381. 
452.  Anonymous. Mobil Oil Advertisement. Time Magazine 1989(Aug 28):7. 
453.  Stirling J. Amblyopia due to Methyl Alcohol. Ophthalmic Review 1905;24:38-40. 
454.  Nagel. CSG. Methyl Alcohol Amblyopia with Special Reference to Optic Nerve: Report of Case. Journal of the American Medical Association 1905(Nov. 18):1560-62. 
455.  McGregor I. A Study of the Histopathological Changes in the Retina and Late Changes in the Visual Field in acute Methyl Alcohol Poisoning. British Journal of Ophthalmology 27:523 1943;27:523-43. 
456.  Gilger A, Potts A. Studies on the Visual Toxicity of Methanol V. The Role of Acidosis in Experimental Methanol Poisoning. American Journal of Opthamology 1955;39ii:63-85. 
457.  Potts A. Dr. Potts is designated as the 1961 laureate for The Jonas S. Friednwald Memorial Lectureship. Investigative Ophthalmology 1962;1(3):283-5. 
458.  Potts A. Retinotoxic and Choroidotoxic Substances: The Jonas S. Friednwald Memorial Lecture. Investigative Ophthalmology 1962;1(3):290-303. 
459.  Van Slyke D. Donald D. Van Slyke: On His 80th Year:. Clin Chem 1963;9(6):646-63. 
460.  Van Slyke D, Palmer W. Studies of acidosis. XVI. The titration of organic acids in urine. J. Biol. Chem. 1920;41:567-85. 
461.  Ruedemann A. The Electroretinogram in Chronic Methyl Alcohol Poisoning in Human Beings. American Ophthalmological Society Annual Meeting 1961;59:480-529. 
462.  see 106. See 106. 
463.  Audet J. Alcool Methilique et Atrophie Optique. Laval Medical 10:446 1945;10:446-51. 
464.  Duke-Elder S. Textbook of Ophthalmology. Vol. VI. Injuries.; 1954. 
465.  Clarren S, Smith D. The Fetal Alcohol Syndrome. N Engl J Med 1978;298:1063-67. 
466.  Shepard T. Catalog of Teratogenic Agents. 2 ed. Baltimore London: The John Hopkins University Press; 1976. 
467.  Jones K, Smith D, Ulleland C, Streissguth A. Pattern of Malformation in Offspring of Chronic Alcoholic Mothers. Lancet 1973;7815(June 9):1267-71. 
468.  Levy L. A form of Immunological Atherosclerosis. In: Advances in Experimental Medicine and Biology. New York.: Plenum Publishing Corp.; 1967. p. 426-32. 
469.  Hennekens C, Rosner B, Cole D. Daily Alcohol Consumption and Fatal Coronary Heart Disease. American Journal of Epidemiology. 1978;107(3):196-200. 
470.  Castelli W. Epidemiology of Coronary Heart Disease; The Framingham Study. American Journal of Medicine 1984(Feb 27):4-12. 
471.  Lipton R, Newman L, Solomon S. Aspartame and Headache. N Engl J Med 1988;318(18):1200-02. 
472.  Smith R. Aspartame Approved Despite Risks. Science 1981;213(28):986-87. 
473.  Dickson D. Aspartame sugar substitute. New court overruled. Nature 292:283 1981;292(July 23):283. 
474.  Ranney R. The Metabolism of the Methyl Moiety of Aspartame. Methanol Metabolism in the Monkey. In: Searle Data Submitted For Aspartame Petition. Document No.MRC-751-0022 (E-92). Chicago: G.D. Searle Inc.; 1963. 
475.  Eng L. Localizations of Spacific Brain Antigens. In: Boese A, editor. Search for the Cause of Multiple Sclerosis and other Chronic Diseases of the Central Nervous System. Basel: Verlag Chemie; 1980. p. 15-460. 
476.  Cooper G, Miller F, Pandey J. The Role of Genetic Factors in Autoimmune Disease: Implications for Environmental Research. Environmental Health Perspectives 107(5):693 1999;107(5):693-700. 
477.  Main R. On the Toxicity of Methyl Alcohol in Extracts and Medicines. The Quarterly Journal of Inebriety 1904;26:146-51. 
478.  Jelliffe S. Multiple Neuritis in Wood Alcohol Poisoning. Medical News 1905(Mar 4):387-90. 
479.  Hufferd R. Optic Neuritis Due to Intoxication With Wood Alcohol. American Pharmaceutical Association 1932;21:548. 
480.  Atchinson J. Methyl (Wood) Alcohol. New York State Journal of Medicine 1905;5:127-28. 
481.  Burhans E. Methyl Alcohol Poisoning. Clinical and Pathological Study of 11 Cases. Illinois Medical Journal 1930;57:260-63. 
482.  Takagi S, Ryoko I, Yamauchi R, Kojima S, Yasuno S, Baba T. Aldehyde Dehydrogenase 2 Gene Is a Risk Factor for Myocardial Infarction in Japanese Men. Hypertens Res 2002;25(5):677-81. 
483.  Hines LM., Meir S, Stampfer J, Jingma H, Gaziano M. Genetic Variation in Alcohol Dehydrogenase and the Beneficial effect of Moderate Alcohol Consumption on Myocardial Infarction. N Engl J Med 2001;344(8):549-55. 
484.  Freiberg M, Samet J. Alcohol and Coronary Heart Disease - The Answer Awaits a Randomized Controlled Trial. Circulation 2005;112:1379-81. 
485.  Klatsky A. Alcohol, wine, and vascular diseases - an abundance of paradoxes. Am J Physiol Heart Circ Physiol 2008;294:582-83. 
486.  Eaton S, Eaton S, Konner M. Paleolithic nutrition revisited- A twelve-year retrospective on its nature and implications. Review EJCN 1997;51:207-16. 
487.  Macdonald L. The Best of Scottish Food and Drink,. London: Little, Brown and Company; 1996. 
488.  Hunt R. The Toxicity of Methyl Alcohol. John Hopkins Hospital Bulletin. 13:213 1902;13:213-25. 
489.  Bergeron R, Cardinal J, Geadah D. Prevention of Methanol Toxicity by Ethanol Therapy. N Engl J Med 1982;307(24):1528. 
490.  see 144. See 144. In:: Elsevier Publishing Company. 
491.  Giolli R, Pope J. The Mode of Innervation of the Dorsal Lateral Geniculate Nucleus and the Pulvinar of the Rabbit by Axons Arising from the Visual Cortex. Journal of Comparative Neur 1973;147:129-43. 
492.  Able EL. Fetal alcohol syndrome: the ‘American Paradox’. Alcohol & Alcoholism 1998;33(3):195-201. 
493.  McCord C. Toxicity of Methyl Alcohol (Methanol) Following Skin Absorption and Inhalation. Industrial and Engineering Chemistry 1931;23(8):931-36. 
494.  see 88. See 88. 
495.  Roe O. Past. Present and Future Fight Against Methanol Blindness and Death. 1970;89:235-42. 
496.  Monte W. Personal Communication. 2006. Bill Richardson Governor of New Mexico. 1/1/2006.; 2006. 
497.  Denton J. Part II Technical Support Document for Describing Available Cancer Potency Factors. California Environmental Protection Agency, Office of Environmental Health Hazard Assessment.; 2002. 
498.  Egg C. Zur Kenntnis der Methylalkohol-Wirkung. Schweizerische Medizinische Wochenschrift 1927;57:5-7. 
499.  Flury F, Wirth W. Methyl Alcohol and Poisoning Methyl Compounds. Archiv fur Gewerbepathologie und Gewerbehygiene 7:221. Archiv Fur Gewerbepathologie Und Gewerbehygiene 1936;7:221-26. 
500.  Keeser E, Vincke E. Uber die Bildung von Formaldehyd Beim Abbau des Methylalkohols. Klin.Wochenschr 1940;19:583-85. 
501.  Terry M, Gammon M, Zhang F, Knight J, Wang Q, Britton J, et al. ADH3 genotype, alcohol intake and breast cancer risk. Carcinogenesis. Carcinogenesis 2006;27(4):840-47. 
502.  Terry M, Gammon M, Zhang F, Vaughan T, Chow W, Risch H, et al. Alcohol dehydrogenase 3 and risk of esophageal and gastric adenocarcinomas. Cancer Causes Control 2007;18(9):1039-46. 
503.  Estonius M, Svensson S, Höög J. Alcohol dehydrogenase in human tissues: localisation of transcripts coding for five classes of the enzyme. FEBS Lett. 1996;397:338-42. 
504.  Seitz H, Egerer G, Simanowski U, Waldherr R, Eckey R, Agarwal D, et al. Human gastric alcohol dehydrogenase activity: effect of age, sex, and alcoholism. Gut 1993;34:1433-37. 
505.  Duester G, Farrés J, Felder M, Holmes R, Höög J, Parés X, et al. Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. Biochem Pharmacol 1999;58(3):389-95. 
506.  Luo Y, Ingram V. Uncoupling of mitochondria activates protein phosphatases and inactivates MBP protein kinases. J Alzheimers Dis 2001;3(6):593-98. 
507.  Kawamura M, Heinecke J, Chait A. Increased uptake of alpha-hydroxy aldehyde-modified low density lipoprotein by macrophage scavenger receptors. J Lipid Res. 41(7):1054 2000;41(7):1054-59. 
508.  Fogelman A, Shechter I, Seager J, Hokom M, Child J, Edwards P. Malondialdehyde alteration of low density lipoproteins leads to cholesteryl ester accumulation in human monocyte-macrophages. Proc Natl Acad Sci. 1980;77(4):2214-8. 
509.  Armstrong S. Ethanol: Brief Report on its use in Gasoline. Cambridge MA.: Cambridge Environmental, Inc. Cambridge MA.; 1999. 
510.  Allen N, Beral V, Casabonne D, Kan S, Gillian K, Reeves G, et al. Moderate Alcohol Intake and Cancer Incidence in Women. JNCI 2009;101:296-305. 
511.  Anton A, Smith D. Breath Analysis for Clinical Diagnosis And Therapeutic Monitoring. Singapore: World Scientific Publishing Company; 2005. 
512.  Jelski W, Szmitkowski M. Alcohol dehydrogenase (ADH) and aldehyde dehydrogenase (ALDH) in the cancer diseases. Clin Chim Acta 2008;395(1-2):1-5. 
513.  Iribarren C, Tekawa I, Sidney S, Friedman G. Effect of cigar smoking on the risk of cardiovascular disease, chronic obstructive pulmonary disease, and cancer in men. N Engl J Med. 1999;340(23):1773-80. 
514.  Kinne R, Bräuer R, Stuhlmüller B, Palombo-Kinne E, Burmeste rG. Macrophages in rheumatoid arthritis. Arthritis Res 2000;2(3):189-202. 
515.  Roman M, Shanker B, Davis A, Lockshin M, Sammaritano LNE. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003;349(25):2399-406. 
516.  Salmon J, Roman M. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus. Am J Med 2008;21(10 Suppl 1):S3-8. 
517.  Gay F, Drye T, Dicdk W, Esiri M. The application of multifactorial cluster analysis in the staging of plaques in early multiple sclerosis. Identification and characterization of the primary demyelinating lesion. Brain 1997;120(Pt 8):1461-83. 
518.  Gay F. Early cellular events in multiple sclerosis. Intimations of an extrinsic myelinolytic antigen. Clin Neurol Neurosurg 2006;108(3):234-40. 
519.  Katsiari C, Liossis S, Sfikakis P. The Pathophysiologic Role of Monocytes and Macrophages in Systemic Lupus Erythematosus; A Reappraisal. Semin Arthritis Rheum 2009(Jan 14):1-13. 
520.  Sherer Y, Gorstein A, Fritzler M, Shoenfeld Y. Autoantibody explosion in systemic lupus erythematosus; more than 100 different antibodies found in SLE patients. Semin Arthritis Rheum 2005;34(2):501-37. 
521.  Kahlert H, Grage-Griebenow E, Stüwe H, Cromwell O, Fiebig H. T cell reactivity with allergoids: influence of the type of APC. J Immunol 2000;165(4):1807-15. 
522.  Marsh D, Lichtenstein L, Campbell D. Studies on “allergoids” prepared from naturally occurring allergens. I. Assay of allergenicity and antigenicity of formalinized rye group I component.(5);705-22. Immunology 1970;18(5):705-22. 
523.  Holgate S. Asthma and allergy--disorders of civilization? QJM 1998;91(3):171-84. 
524.  Herbert M, Russo J, Yang S, Roohi J, Blaxill M, Kahler S, et al. Autism and environmental genomics. Neurotoxicology 2006;27(5):671-84. 
525.  Blaxill M. What’s going on? The question of time trends in autism. Public Health 2004;119(6):536-51. 
526.  Kern J. Purkinje cell vulnerability and autism: a possible etiological connection. Brain Dev 2006;25(6):377-82. 
527.  Jepson B. Changing the Course of Autism: A Scientific Approach for Parents and Physicians. Boulder, Colorado: Sentient Publications; 2007. 
528.  Galter D, Carmine A, Buervenich S, Duester G, Olson L. Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain. Eur J Biochem 2003;270(6):1316-26. 
529.  McCarver D, Thomasson H, Martier S, Sokol R, Li T. Alcohol dehydrogenase-2*3 allele protects against alcohol-related birth defects among African Americans. J Pharmacol Exp Ther 1997;283(3):1095-101. 
530.  McCarver D. ADH2 and CYP2E1 Genetic Polymorphisms: Risk Factors forAlcohol-Related Birth Defects. Drug Metabolism and Disposition 2001;29(4-2):562-65. 
531.  Zakhari S. Overview: how is alcohol metabolized by the body? Alcohol Res Health 2006;29(4):245-54. 
532.  Yusuf S, Ounpuu S, Anand S. The global epidemic of atherosclerotic cardiovascular disease. Med Princ Pract 2002;11(Suppl 2):3-8. 
533.  Waldman M. Are We Experiencing an Alzheimer’s Epidemic? Presentation (Abstract 90) [AD/PD 2009: 9th International Conference on Alzheimer’s and Parkinson’s Diseases:].; 2009. 
534.  Sink K. Moderate Alcohol Consumption May Lower Dementia Risk in Cognitively Normal Elderly. Presentation. Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD); ; Vienna. medscape; 2009. 
535.  Mehlig K, Skoog I, Guo X, Schütze M, Gustafson D, Waern M, et al. Alcoholic Beverages and Incidence of Dementia: 34-Year Follow-up of the Prospective Population Study of Women in Göteborg. Am J Epidemiol 2008;167(6):684-91. 
536.  Uramoto K, Michet C, Thumboo J, Sunku J, O’Fallon W, Gabriel S. Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum 1999;42(1):46-50. 
537.  Anonymous. Methanol, IPCS. Geneva: International Programme On Chemical Safety World Health Organization; 1997. 
538.  Burbacher T, Grant K, Shen D, Sheppard L, Damian D, Ellis S, et al. Chronic maternal methanol inhalation in nonhuman primates (Macaca fascicularis): reproductive performance and birth outcome. Neurotoxicol Teratol 2004;26(5):639-50. 
539.  Bartzokis G, Cummings J, Sultzer D, Henderson V, Nuechterlein K, Mintz J. White Matter Structural Integrity in Healthy Aging Adults and Patients With Alzheimer Disease. Arch Neurol 2003;60(3):393-8. 
540.  Casserly I, Topol E. Convergence of atherosclerosis and Alzheimer’s disease: inflammation, cholesterol, and misfolded proteins. Lancet 2004;363(9415):1139-46. 
541.  Main R. Death from Poisoning by Methyl Alcohol. The Learned Coroner. Illinois Medical Journal 1904;27:146-54. 
542.  Mathews W. McAlpine’s Multiple Sclerosis, Fourth Edition. 4 ed.; 2005. 
543.  Stechschulte S, Jacob S. Formaldehyde, aspartame, migraines: a possible connection.(author reply). Dermatitis 2009;20(3):177-9. 
544.  Abegaz E, Bursey R. Formaldehyde, aspartame, migraines: a possible connection.(comment on). Dermatitis 2009;20(3):176-7. 
545.  Hill A, Belsito D. Systemic contact dermatitis of the eyelids caused by formaldehyde derived from aspartame? Contact Dermatitis 2003;49(5):258-9. 
546.  Chapman L. Experimental Induction of Hangover. Q J Stud Alcohol 1970;5:67-86. 
547.  Oppermann JA, Muldoon E, Ranney R. Metabolism of Aspartame in Monkeys. Journal of Nutrition 1973;103(10):1454-59. 
548.  Bouchard M, Brunet R, Droz P, Carrier G. A Biologically Based Dynamic Model for Predicting the DispositionOf Methanol and Its Metabolites in Animals and Humans. Toxicological Sciences 2001;64:169-84. 
549.  Nabors LOB. Calorie Control Council Objections to NTP-CERHR 2002, Letter September 7,2001. In: NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methanol. 2003. U.S. Department of Health and Human Services; 2001. 
550.  Sandler J. PETA, People for the Ethical Treatment of Animals Objections to NTP-CERHR 2002. Letter dated June 8, 2002. In: NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methanol. 2003. U.S. Department of Health and Human Services; 2003. 
551.  Davis J, Barone S. Dr. Davis and Dr. Barone, CERHR committie members, object to Bias of final report. NTP-CERHR 2002. Letters dated July 3 - 8 2002. In: NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methanol. 2003. U.S. Department of Health and Human Services; 2003. 
552.  Lynn J. Methanol Institute Objections to NTP-CERHR 2002.Letter dated July 3, 2002. In: NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methanol. 2003. U.S. Department of Health and Human Services; 2003. 
553.  Festa J. American Forest Paper Association Objections to NTP-CERHR 2002. Letter dated July 8, 2002. In: NTP-CERHR Monograph on the Potential Human Reproductive and Developmental Effects of Methanol. 2003. U.S. Department of Health and Human Services; 2003. 
554.  Matthews W. McAlpine’s Multiple Sclerosis. Second Edition. 2 ed. London: Churchill Livingston - Elsevier.; 1991. 
555.  Adams D. The Granulomatous Inflammatory Response: A Review. American Journal of Pathology 1976;41(1):164-92. 
556.  Williams G, Williams W. Granulomatous inflammation--A review. J Clin Pathol 1983;36(7):723-33. 
557.  Purdue M, Beane Freeman L, Anderson W, Tucker M. Recent Trends in Incidence of Cutaneous Melanoma among US Caucasian Young Adults. Journal of Investigative Dermatology (2008) 128, 29052908; Doi:10.1038/Jid.2008.159; Published Online 10 July 2008 2008;128(12):2905-08. 
558.  Nagarajan R, Patzel K, Martin M, Yasui D, Swanberg S, Hertz-Picciotto I, et al. MECP2 promoter methylation and X chromosome inactivation in autism. Autism Research 2008;1(3):169-78. 
559.  Nagarajan R, Hogart A, Gwye Y, Martin M, LaSalle J. Reduced MeCP2 expression is frequent in autism frontal cortexAnd correlates with aberrant MECP2 promoter methylation. Epigenetics 2006;1(4):e1-11. 
560.  Sadikovic B, Al-Romaih K, Squire J, Zielenska M. Cause and consequences of genetic and epigenetic alterations in human cancer. Curr Genomics 2008;9(6):394-408. 
561.  Selye H. Further sutdies concerning the participation of the Adrenal Cortex in the Pathogenesis of Arthritis. British Medical Journal 1949;19(2(4637)):1129-35. 
562.  Gardner. DL. The Experimental Production of Arthritis. Ann Rheum Dis 1960;19(4):297-317. 
563.  Scott B, Weisbrot L, Greenwood J, Bogoch E, Paige C, Keystone E. Rheumatoid Arthritis Synovial Fibroblast and U937 Macrophage/Monocyte Cell Line Interaction In Cartilage Degradation. 2005;40(3):490-98. 
564.  Siragusa R, Cerda J, Baig M, Burgin C, Robbins F. Methanol production from the degradation of pectin by human colonic bacteria. Am J Clin Nutr 1988;47:848-51 1988;47:848-51. 
565.  Pine S, Sanchez B. The Formic Acid-Formaldehyde Methylation of Amines. J Org Chem 1971;36(6):829-43. 
566.  Fu S, Sakanashi T, Rogers J, Hong K, Keen C. Influence of dietary folic acid on the developmental toxicity of methanol and the frequency of chromosomal breakage in the CD-1 mouse. Reproductive Toxicology 1996;10(6):455-63. 
567.  Olek S, Maier S, Olek K, Olek A. Digitizing Molecular Diagnostics: Current and Future Aplications of Epigenome Technology. In: Beck S, Olek A, editors. The Epigenome. Weinheim: Wiley-VCH; 2003. p. 153-70. 
568.  Aziz M, Agrawal A, Adhami V, Ali M, Baig M, Seth P. Methanol-induced neurotoxicity in pups exposed during lactation through mother: Role of folic acid. Neurotoxicology and Teratology 2002;24(4):519-27. 
569.  Huanga Y, Heldb G, Andrewsb J, Rogersb J. C14 methanol incorporation into DNA and proteins of organogenesis stage mouse embryos in vitro. Reproductive Toxicology 15 (2001) 429435 2001;15:429-35. 
570.  Mitchell S, Reiss A, Tatusko D, Ikuta I, Kazmerski D, Botti J, et al. Neuroanatomic alterations and social and communication deficits in monozygotic twins discordant for autism disorder. Am J Psychiatry 2009;166(8):917-25. 
571.  Webb S, Sparks B, Friedman S, Shaw D, Giedd J, Dawson G, et al. Cerebellar vermal volumes and behavioral correlates in children with autism spectrum disorder. Psychiatry Res 2009;172(1):61-7. 
572.  Indredavik M, Brubakk A, Romundstad P, Vik T. Prenatal smoking exposure and psychiatric symptoms in adolescence. Acta Paediatr 2007;96(3):377-82. 
573.  Hultman C, Sparén P, Cnattingius S. Perinatal risk factors for infantile autism. Epidemiology 2002;13(4):417-23. 
574.  Croghan I, Pruthi S, Hays J, Cha S, Johnson R, Kosel M, et al. The role of smoking in breast cancer development: an analysis of a Mayo Clinic cohort. Breast J 2009;15(5):489-95. 
575.  Reynolds P, Hurley S, Goldberg D, Anton-Culver H, Bernstein L, Deapen D, et al. Active smoking, household passive smoking, and breast cancer: evidence from the California Teachers Study. J Natl Cancer Inst 2004 Jan 7;96(1):29-37 2004;96(1):29-37. 
576.  American Cancer Society. Breast Cancer Facts & Figures 2007-2008. Atlanta, GA: American Cancer Society, Inc.; 2008. 
577.  Horner M, Ries L, Krapcho M, Neyman N, Aminou R, Howlader N, et al. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda, MD,, based on November 2008 SEER data submission, posted to the SEER web site, 2009. Bethesda, MD: National Cancer Institute.; 2008. 
578.  Agency for Toxic Substances and Disease Registry. Health Consultation; Village of Wellington, Environmental Contamination Concerns. Ohio Department of Health: U.S. Department of Health and Human Services; 2005. 
579.  Agency for Toxic Substances and Disease Registry. Petitioned Public Health Assessment, LaFarge Corporation - Alpena Plant, Alpena, Alpena County, Michigan. U.S. Department of Health and Human Services; 2001. 
580.  Riise T, Moen B, Kyvik K. Organic solvents and the risk of multiple sclerosis. Epidemiology 2002;13(6):718-20. 
581.  Witte M, Bø L, Rodenburg R, Belien J, Musters R, Hazes T, et al. Enhanced Number and Activity of Mitochondria in Mutiple Sclerosis Lesions. J Pathol 2009;219(2):193-204. 
582.  Seme M, Summerfelt P, Neitz J, Eells J, Henry M. Differential Recovery of Retinal Function after Mitochondrial Inhibition by Methanol Intoxication. Invest Ophthalmol Vis Sci 2001;42(3):834-41. 
583.  Miller A, To T, Baines C, Wall C. The Canadian National Breast Screening Study-1: breast cancer mortality after 11 to 16 years of follow-up. A randomized screening trial of mammography in women age 40 to 49 years. Ann Intern Med 2002;137(5 Part 1):305-12. 
584.  Zampolla T, Spikings E, Zhang T, Rawson D. Effect of methanol and Me2SO exposure on mitochondrial activityAnd distribution in stage III ovarian follicles of zebrafish (Danio rerio). Cryobiology 2009;59:188-98. 
585.  Hoffmann D, Hoffmann I. Chapter 5; The Changing Cigarette: Chemical Studies and Bioassays. In:Shopland D, Burns D, Benowitz N, Amacher R, editors. Risks Associated with Smoking Cigarettes with Low Machine-Measured Yields of Tar and Nicotine - Monograph No. 13 U.S. Department of Health and Human Services: National Cancer Institute, U. S. National Institutes of Health; 2001. p. 160-70. (Smoking and Tobacco Control Monographs; vol. 13). 
586.  Monte W. Methanol: A chemical Trojan horse as the root of the inscrutable U. Med Hypotheses 2010;74(3):493-6. 
587.  Hayflick L. The Quest for Immortality:Science at the Frontiers of Aging. Radiation Research 2001;156(3):334-36. 
588.  Lin JC, GC. Associations of Sugar and Artificially Sweetened Soda with Albuminuria and Kidney Function Decline in Women.[Epub ahead of print] doi: 10.2215/CJN.03260410. Clin J Am Soc Nephrol. 2010(Sep 30). 
589.  Altaweel M, Hanzlik R, Ver Hoeve J, Eells J, Zhang B. Ocular and systemic safety evaluation of calcium formate as a dietary supplement. J Ocul Pharmacol Ther 2009;25(3):223-30. 
590.  Kamino K, Nagasaka K, Imagawa M, Yamamoto H, Yoneda H, Ueki A, et al. Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer’s disease in the Japanese population. Biochem Biophys Res Commun 2000;273(1):192-6. 
591.  Tong Z, Zhang J, Luo W, Wang W, Li F, Li H, et al. Urine formaldehyde level is inversely correlated to mini mental state examination scores in senile dementia. Neurobiol Aging 2009. 
592.  Ohsawa I, Kamino K, Nagasaka K, Ando F, Niino N, Shimokata H, et al. Genetic deficiency of a mitochondrial aldehyde dehydrogenase increases serum lipid peroxides in community-dwelling females. J Hum Genet 2003;48(8):404-9. 
593.  Fox C, Johnson F, Whiting J, Roller P. Formaldehyde Fixation. J Histochem Cytochem 1985;33(8):845-53. 
594.  Levy M. The Acidity of Formaldehyde and the end point of the Formol Titration. J Biol Chem 1933;105(1):157-65. 
595.  Casanova M, Heck H, Janszen D. Comments on ‘DNA-protein crosslinks, a biomarker of exposure to formaldehyde--in vitro and in vivo studies’ by Shaham et al. Carcinogenesis 1996;17(9):2097-101. 
596.  Shaham J, Bomstein Y, Meltzer A, Kaufman Z, Palma E, Ribak J. DNA--protein crosslinks, a biomarker of exposure to formaldehyde--in vitro and in vivo studies. Carcinogenesis. 1996 Jan;17(1):121-5. 1996;17(1):121-5. 
597.  Offit P, Jew R. Addressing parents’ concerns: do vaccines contain harmful preservatives, adjuvants, additives, or residuals? Pediatrics. 2003 Dec;112(6 Pt 1):1394-7 2003;112(6 Pt 1):1394-7. 
598.  Park A. Autism Numbers Are Rising. The Question is Why? Time 2009;2009(21):55-6. 
599.  Schechter R, Grether J. Continuing increases in autism reported to California’s developmental services system: mercury in retrograde. Arch Gen Psychiatry 2008;65(1):19-24. 
600.  Rutter M. Incidence of autism spectrum disorders: changes over time and their meaning. Acta Paediatr. 2005 Jan;94(1):2-15. 2005;94(1):2-15. 
601.  Anonymous. Histone demethylation 2009 [cited 12/25/2009]. Available from: URL: 
602.  Bannister A, Schneider R, Kouzarides T. Histone methylation: dynamic or static? Cell. 2002 Jun 28;109(7):801-6 2002;109(7):801-6. 
603.  Kutschera U. Plant-Associated Methlobacteria as Co-Evolved Phytosymbionts. Plant Signaling & Behavior 2007;2(2):74-8. 
604.  Pham M, Lemberg D, Day A. Probiotics: sorting the evidence from the myths. Med J Aust 2008;188:304-8. 
605.  Trager R. Formaldehyde politics block research chief joining EPA. RSC Advancing the Chemical Sciences; 2009. 
606.  Kiernan J. Formaldehyde, formalin, paraformaldehyde and glutaraldehyde:What they are and what they do. Microscopy Today 2000;00(1):8-12. 
607.  Lehninger A. Biochemistry, The Molecular Components of Cells pp. 80. 2 ed. New York, New York: Worth Publishers, Inc.; 1975. 
608.  McDonald W. The mystery of the origin of MS. Journal of Neurology, Neurosurgery, and Psychiatry 1986;49:113-23. 
609.  Putnam T. The Centenary of Miltiple Sclerosis. Arch Neurol Psychiatry 1938;40(4):806-13. 
610.  Lucas A, Greaves D. Atherosclerosis: role of chemokines and macrophages. Expert Rev Mol Med 2001;3(25):1-18. 
611.  Pisarik P, Kai D. Vestibulocochlear toxicity in a pair of siblings 15 years apart secondary to aspartame: two case reports. Cases Journal 2009, 2:9237 2009;2:9237. 
612.  Rowley B, Lund D, Richardson T. Reductive Methylation of Lactoglobulin with Formaldehyde. J Dairy Sci 62:533--536 1979;62:533-36. 
613.  Kim H, Cho E, Bae J, Yu D, Oh S, Kang H, et al. Recent trend in the incidence of premalignant and malignant skin lesions in Korea between 1991 and 2006. J Korean Med Sci. 2010;25(6):924-29. 
614.  Sicotte N, Kern K, Giesser B, Arshanapalli A, Schultz A, Montag M, et al. Regional hippocampal atrophy in multiple sclerosis. Brain 2008;131(Pt 4):1134-41. 
615.  Behan P, Roep B. The pathogenesis of multiple sclerosis revisited. J R Coll Physicians Edinb 2002;32:244265. 
616.  Compston A. Revisiting The pathogenesis of multiple sclerosis revisited. Int MS J. 2003;10(1):29-31. 
617.  Halldorsson T, Strøm M, Petersen S, Olsen S. Intake of artificially sweetened soft drinks and risk of preterm delivery: a prospective cohort study of 59,334 Danish pregnant women. Am J Clin Nutr Doi:10.3945/Ajcn.2009.28968 2010. 
618.  Rico E, Rosemberg D, Senger M, Arizi MB, Bernardi G, Dias R, et al. Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 2006;28(4):489-96. 
619.  Simintzi I, Schulpis K, Angelogianni P, Liapi C, Tsakiris S. The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats. Pharmacol Res. 2007;56(2):155-9. 
620.  Dawson J. The Histology of Disseminated Sclerosis. Trans Royal Soc Edin 1916;50:517-740. 
621.  Hitler A. Mein Kampf.: Project Gutenberg of Australia eBook; 2002. 
622.  Allen G., Courchesne E. Differential effects of developmental cerebellar abnormality on cognitive and motor functions in the cerebellum: an fMRI study of autism. Am J Psychiatry 2003;160(2):262-73. 
623.  Simintzi I, Schulpis K, Angelogianni P, Liapi C, Tsakiris S. The effect of aspartame on acetylcholinesterase activity in hippocampal homogenates of suckling rats. Pharmacol Res. 2007;56(2):155-9. 
624.  Tsakiris S, Schulpis K. Answer to letter sent by A.G. Renwick related to Simintzi et al. report published in Food and Chemical Toxicology 2007;45(12):2397-401. Food Chem Toxicol. 2008;46:1208-09. 
625.  Tsakiris S, Schulpis K. Answer to letter sent by E. Abegaz and R. Bursey Ajinimoto Corporation Washington USA related to Simintizi et al report published in Pharmacol Res 2007;56155-9. Pharmocol Res. 2008;57:89-90. 
626.  Dorman D, Welsch F. Developmental Toxicity of Methanol in Rodents. Chemical Industry Institute of Toxicology Activities 1996;16(2):1-7. 
627.  Shelby M. NTP-CERHR Expert Panel report on the reproductive and developmental toxicity of methanol. Reproductive Toxicology 2004;18:303-90. 
628.  Holahan CJ., Schutte KK., Brennan PL., Holahan CK., Moos BS., Moos RH. Late-Life Alcohol Consumption and 20-Year Mortality. Alcohol Clin Exp Res, Vol 34, No 11, 2010: Pp 111 2010;34(11):1-11. 
629.  Fediuk K. Vitamin C in the Intuit diet: past and present. McGill University, Montreal: School of Dietetics and Human Nutrition; 2000. 
630.  Castanedo-Tardan MP., González ME., Connelly EA., Giordano K., Jacob SE. Systematized contact dermatitis and montelukast in an atopic boy. Pediatr Dermatol 2009;26(6):739-43. 
631.  Verhelst D., Moulin P., Haufroid V., Wittebole X., Jadoul M., Hantson P. Acute renal injury following methanol poisoning: analysis of a case series. Int J Toxicol 2004;23(4):267-73. 
632.  Lee E., Brady AN., Brabec MJ., Fabel T. Effects of methanol vapors on testosterone production and testis morphology in rats. Toxicol Ind Health 1991;7(4):261-75. 
633.  Saha AK., Khudabaksh AR. Chromosome aberrations induced by methanol in germinal cells of grasshopper, Oxya velox Fabricius. Indian J Exp Biol. 1974;12(1):72-5. 
634.  Rincÿ3n ID., Williams K., Stern MP., Freeman GL., Escalante A. High Incidence of Cardiovascular Events in a Rheumatoid Arthritis Cohort Not Explained by Traditional Cardiac Risk Factors. Arthritis & Rheumatism 2001;44(12):2737-45. 
635.  Myasoedova E., Crowson CS., Kremers HM., Therneau TM., Gabriel SE. Is the incidence of rheumatoid arthritis rising?: results from Olmsted County, Minnesota, 1955-2007. Arthritis Rheum 2010;62(6):1565-7. 
636.  Deltour L., Haselbeck RL., Ang HL., Duester G. Localization of Class I and Class IV Alcohol Dehydrogenases in Mouse Testis and Epididymis: Potential Retinol Dehydrogenases for Endogenous Retinoic Acid Synthesis. Biology of Reproduction 1997;56(1):102-9. 
637.  Bühler R., Pestalozzi D., Hess M., Von Wartburg JP. Immunohistochemical localization of alcohol dehydrogenase in human kidney, endocrine organs and brain. Pharmacol Biochem Behav. 1983;18 Suppl 1:55-9 1983;18(Suppl 1):55-9. 
638.  Petersen BJ., Cornell NW., Veech RL. Alcohol dehydrogenase in cultured human skin fibroblasts. Human fibroblast alcohol dehydrogenase. Adv Exp Med Biol 1980;132:533-41. 
639.  Poon R., Chu I., Bjarnason S., Potvin M., Vincent R., Miller RB., et al. Inhalation toxicity study of methanol, toluene, and methanol/toluene mixtures in rats: effects of 28-day exposure. Toxicol Ind Health. 1994 May-Jun;10(3):231-45 1994;10(3):231-45. 
640.  Smith M., Hopkinson DA., Harris H. Developmental changes and polymorphism in human alcohol dehydrogenase. Ann Hum Genet 1971;34(3):251-71. 
641.  COPD International. COPD Statistical Information 2010. Available from: URL: 
642.  Maxwell JR., Gowers IR., Moore DJ., Wilson AG. Alcohol consumption is inversely associated with risk and severity of rheumatoid arthritis. Rheumatology 2010;49(11). 
643.  Almeida OP., Hulse GK., Lawrence D., Flicker L. Smoking as a Risk Factor for Dementia and Cognitive Decline: A Meta-Analysis of Prospective Studies. Addiction 2002;97(1):15-28. 
644.  Hultman CM., Sparén P., Cnattingius S. Perinatal risk factors for infantile autism. Epidemiology. 2002 Jul;13(4):417-23. 2002;13(4):417-23. 
645.  De Hertog SA., Wensveen CA., Bastiaens MT., Kielich CJ., Berkhout MJ., Westendorp RG., et al. Relation between smoking and skin cancer. J Clin Oncol 2001;19(1):231-8. 
646.  Chow WH., Devesa SS., Warren JL., Fraumeni JF Jr. Rising incidence of renal cell cancer in the United States. JAMA. 1999;281(17):1628-31. 
647.  Schulze MB, Manson JE., Ludwig DS., Colditz GA., Stampfer MJ., Willett WC., et al. Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women. JAMA 2004;292(8):927-34. 
648.  Willi C., Bodenmann P., Ghali WA., Faris PD., Cornuz J. Active smoking and the risk of type 2 diabetes: a systematic review and meta-analysis. JAMA 2007;298(22):2654-64. 
649.  Pinhas-Hamiel O., Dolan LM., Daniels SR., Standiford D., Khoury PR., Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr 1996;128(5 Pt. 1):608-15. 
650.  Magis DC., Jandrain BJ., Scheen AJ. Alcohol, insulin sensitivity and diabetes. Rev Med Liege 2003;58(7-8):501-7. 
651.  Ejerblad E., Fored CM., Lindblad P., Fryzek J., Dickman PW., Elinder CG., et al. Association between smoking and chronic renal failure in a nationwide population-based case-control study. J Am Soc Nephrol 2004;15(8):2178-85. 
652.  Hunt JD., van der Hel OL., McMillan GP., Boffetta P., Brennan P. Renal cell carcinoma in relation to cigarette smoking: Meta-analysis of 24 studies. Int J Cancer. 2005 Mar 10;114(1):101-8. 2005;114(1):101-8. 
653.  Asztalos E. The need to go beyond: evaluating antenatal corticosteroid trials with long-term outcomes. J Obstet Gynaecol Can 2007;29(5):429-32. 
654.  Shiono PH., Klebanoff MA., Rhoads GG. Smoking and drinking during pregnancy. Their effects on preterm birth. JAMA 1986;255(1):82-4. 
655.  Thun MJ., Lally CA., Flannery JT., Calle EE., Flanders WD., Heath CW Jr. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 1997;89(21):1580-6. 
656.  Navab R., Bandarchi B., Tsao M-S. Carcinoma-Associated Fibroblasts in Lung Cancer. In: Keshamouni V., Arenberg D., Kalemkerian G, editors. Lung Cancer Metastasis; Novel Biological Mechanisms and Impact on Clinical Practice. DOI: 10.1007/978-1-4419-0772-1_10: SpringerLink; 2009. p. 193-215. 
657.  Soffritti M., Belpoggi F., Manservigi M., Tibaldi E., Lauriola M., Falcioni L., et al. Aspartame Administered in Feed, Beginning Prenatally Through Life Span, Induces Cancers of the Liver and Lung in Male Swiss Mice. Am J Ind Med 2010. 
658.  Nielsen NM., Rostgaard K., Rasmussen S., Koch-Henriksen N., Storm HH., Melbye M, et al. Cancer risk among patients with multiple sclerosis: a population-based register study. Int J Cancer 2006;118(4):979-84. 
659.  Martins MRI., Azoubel R. Effects of Aspartame on Fetal Kidney: A Morphometric and Stereological Study. Int J Morphol 2007;25(4):689-94. 
660.  Portari GV., Mathias MGM., Almeida BB., Marchini JS., Jordao AA. Effect of the Temperature and pH on Methanol Release in Coffee Brew Sweetened with Aspartame. Acta Alimentaria 2009;38(3):303-7. 
661.  Anonymous. Formic acid Material Safety Data Sheet. Scholar Chemistry and Columbus Chemical Industries, Inc.; 2009. 
662.  Environmental Risk Management Authority of New Zealand. ERMA New Zealand makes meths safer. New Zealand Environmental Risk Management Authority; 2007. 
663.  Duester G. Families of retinoid dehydrogenases regulating vitamin A functionProduction of visual pigment and retinoic acid. Eur. J. Biochem 2000;267:4315-24. 
664.  Delille HK., Alves A., Schrader M. Biogenesis of peroxisomes and mitochondria: linked by division. Histochem Cell Biol 2009;131:441-6. 
665.  Tephly TR., Watkins WD, Goodman JI. The Biochemical Toxicology of Methanol. New York and London: Acidemic Press; 1974. (Hayes JH., ed. Essays In Toxicology; vol. 5). 
666.  Chao MJ., Ramagopalan SV., Herrera BM., Orton SM., Handunnetthi L., Lincoln MR., et al. MHC transmission: Insights into gender bias in MS susceptibility. Neurology 2011;76(2). 
667.  Cong R., Zhou B., Sun Q., Gu H., Tang N., Wang B. Smoking and the risk of age-related macular degeneration: a meta-analysis. Ann Epidemiol 2008;18(8):647-56. 
668.  Evans J., Wormald R. Is the incidence of registrable age-related macular degeneration increasing? British Journal of Ophthalmology 1996;80:9-14. 
669.  McKinley MG. Alcohol Withdrawal Syndrome Overlooked and Mismanaged? Critical Care Nurse 2005;25(3):40-9. 
670.  Becker CE. Acute Methanol Poisoning - The Blind Drunk. West J. Med. 1981;135:122-28. 
671.  Prabhakaran V., Ettler H., Mills A. Methanol poisoning; Two cases with similar plasma methanol concentrations but different outcomes. Can Med Assoc J 1993;148(6):981-84. 
672.  Paasma R., Hovda KE., Jacobsen D. Methanol poisoning and long term sequelae - a six years follow-up after a large methanol outbreak. BMC Clin Pharmacol 2009;27(9):1-5. 
673.  Hovda KE., Hunderi OH., Tafjord AB., Dunlop O., Rudberg N., Jacobsen D. Methanol outbreak in Norway 2002-2004: epidemiology,Clinical features and prognostic signs. J Intern Med 2005;258(2):181-90. 
674.  Jacobsen D., Jansen H., Wiik-Larsen E., Bredesen JE., Halvorsen S. Studies on methanol poisoning. Acta Med Scand 1982;212(1-2):5-10. 
675.  Cursiefen C., Bergua A. Acute bilateral blindness caused by accidental methanol intoxication during fire “eating”. Br J Ophthalmol. 2002 Sep;86(9):1064-5 2002;86(9):1064-5. 
676.  Cornblatt JA. The Water Channel of Cytochrome c Oxidase: inferences fromInhibitor Studies. Biophys J. 1998 Dec;75(6):3127-34 1998;75(6):3127-34. 
677.  Collins TFX. Memorandum: Aspartame shown to cause nural tube birth defects in the New Zealand rabit, an animal very resistant to methanol poisoning. Freedom of information: Department of Health Education and Welfare, Food and Drug Administration; 1978. 
678.  anonymous. Seventeenth Report of the Joint FAOWHO Expert Committee on Food Additives, Formic Acid. FAO WHO; 1973. 
679.  Christie RH., Freeman M., Hyman BT. Expression of the Macrophage Scavenger Receptor, a Multifunctional Lipoprotein Receptor, in Microglia Associated with Senile Plaques in Alzheimer’s Disease. Amer J Path 1996;148(2):399-403. 
680.  Roe O. Clinical Investigations of methyl alcohol poisoning with special references to the pathogenesis and teatment of amblyopia. Acta Med Scand 1943;63:558-605. 
681.  Fisher MA. The Toxic Effect of Formaldehyde and Formalin. J Exp Med 1905;6:487-518. 
682.  Moore KJ. Freeman MW. Targeting Innate Immunity for Cardio Vascular Benefit. Drug Discov Today Ther Strateg 2008;5(1):15-23. 
683.  Holman RL., McGill HC., Strong JP., Geer JC. The Natural History of Atherosclerosis. Amer J Path 1958;34(2):209-35. 
684.  Marrugat J., Sala J., Aboal J. Epidemiology of cardiovascular disease in women. Rev Esp Cardiol 2006;59(3):264-74. 
685.  U.S. Environmental Protection Agency. Toxicoilogical Review of Methanol EPA/6.35/R-09/013. Draft ed. U.S. Environmental Protection Agency; 2010. 
686.  Gardener H. Diet Soda Tied to Vascular Risk “Soda consumption and risk of vascular events in the northern Mahattan Study ASA 2011 Abstract P55. American Stroke Association’s International Stroke Conference; 2011; Los Angeles. 
687.  Berneisa K., Rizzob M. LDL Size; Does it Matter? Swiss Med Wkly 2004;134:720-24. 
688.  Baker JR. Principles of biological microtechnique. London, UK.: Methuen; 1958. 
689.  Blomhoff R., Eskild W., Berg T. Endocytosis of formaldehyde-treated serum albumin via scavenger pathway in liver endothelial cells. Biochem J 1984;218:81-6. 
690.  Kaesberg B., Harrach B., Dieplinger H., Robenek H. In situ immunolocalization of lipoproteins in human arteriosclerotic tissue. Arterioscler Thromb 1993;13(1):133-46. 
691.  Smedsrød B., Melkko J., Araki N., Sano H., Horiuchi S. Advanced glycation end products are eliminated by scavenger-receptormediated endocytosis in hepatic sinusoidal Kupffer and endothelial cells. Biochem J 1997;322:567-73. 
692.  Harrach B., Robenek H. Polyclonal antibodies against formaldehyde-modified apolipoprotein A-I. An approach to circumventing fixation-induced loss of antigenicity in immunocytochemistry. Arteriosclerosis 1990;10(4):564-76. 
693.  Murthy VK., Monchesky TC., Steiner G. In vitro labeling of beta-apolipoprotein with 3H or 14C and preliminary application to turnover studies. J Lipid Res 1975;16(1):1-6. 
694.  Ciappuccini R., Ansemant T., Maillefert JF., Tavernier C., Ornetti P. Aspartame-induced fibromyalgia, an unusual but curable cause of chronic pain. Clin Exp Rheumatol 2010;28(6 Sup 63):S131-3. 
695.  Soffritti M., Belpoggi F., Manservigi M., Tibaldi E., Lauriola M., Falcioni L., et al. Aspartame administered in feed, beginning prenatally through life span, induces cancers of the liver and lung in male Swiss mice. Am J Ind Med 2010;53(12):1197-206. 
696.  Cataldo JK., Prochaska JJ., Glantz SA. Cigarette smoking is a risk factor for Alzheimer’s Disease: an analysis controlling for tobacco industry affiliation. J Alzheimers Dis 2010;19(2):465-80. 
697.  Hashimoto M., Rockenstein E., Crews L., Masliah E. Role of protein aggregation in mitochondrial dysfunction and neurodegeneration in Alzheimer’s and Parkinson’s diseases. Neuromolecular Med 2003;4(1-2):21-36. 
698.  Hernández F., Avila J. Tauopathies. Cell Mol Life Sci 2007;64(17):2219-33. 
699.  Surdacki A., Martens-Lobenhoffer J., Wloch A., Marewicz E., Rakowski T., Wieczorek-Surdacka E., et al. Elevated Plasma Asymmetric Dimethyl-L-Arginine Levels Are Linked to Endothelial Progenitor Cell Depletion and Carotid Atherosclerosis in Rheumatoid Arthritis. Arthritis Rheum 2007;56(3):809-19. 
700.  Vallance P., Leiper J. Cardiovascular Biology of the Asymmetric Dimethylarginine: Dimethylarginine Dimethylaminohydrolase Pathway. Arterioscler Thromb Vasc Biol 2004;24:1023-30. 
701.  Sacks JJ., Helmick CG., Langmaid G., Sniezek JE. Trends in Deaths from Systemic Lupus Erythematosus --- United States, 1979--1998. Morbidity and Mortality Weekly Report 2002;51(17):371-4. 
702.  Nettleton J., et al. Diet Soda Intake and Risk of Incident Metabolic Syndrome and Type 2 Diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA). Diabetes Care 2009;32:688-94. 
703.  Mölsä PK., Marttila RJ., Rinne UK. Long-term survival and predictors of mortality in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand 1995;91(3):159-64. 
704.  Mölsä PK., Marttila RJ., Rinne UK. Survival and cause of death in Alzheimer’s disease and multi-infarct dementia. Acta Neurol Scand. 1986 Aug;74(2):103-7 1986;74(2):103-7. 
705.  Matsumoto R., Nakano I., Shiga J., Akaoka I. Systemic lupus erythematosus with multiple perivascular spongy changes in the cerebral deep structures, midbrain and cerebellar white matter: a case report. J Neurol Sci 1997;145(2):147-53. 
706.  Yocum AK., Chinnaiyan AM. Current affairs in quantitative targeted proteomics: multiple reaction monitoring-mass spectrometry. Brief Funct Genomic Proteomic 2009;8(2):145-57. 
707.  Adams CW., Bayliss OB., Hallpike JF, Turner DR. Histochemistry of myelin. XII. Anionic straining of myelin basic proteins for histology, electrophoresis and electron microscopy. J Neurochem 1971;18(3):389-94. 
708.  Schultz M., et. al. Alcohol attributable burden of incidence of cancer in eight European countries based on results from prospective cohort study. British Medical Journal 2011;342:1-10. 
709.  Zhang L., Tang X., Rothman N., Vermeulen R., et. al. Occupational exposure to formaldehyde, hematotoxicity, and leukemia-specific chromosome changes in cultured myeloid progenitor cells. Cancer Epidemiol Biomarkers Prev 2010;19(1):80-8. 
710.  Lai SM., Zhang ZX., Alter M., Sobel E. World-wide trends in multiple sclerosis mortality. Neuroepidemiology 1989;8(2):56-67. 
711.  Wills S., Rossi CC., Bennett J., Martinez-Cerdeno V., Ashwood P., Amaral DG., et al. Further characterization of autoantibodies to GABAergic neurons in the central nervous system produced by a subset of children with autism. Molecular Autism 2011;2(1):5. 
712.  Gale AME. The rise of childhood type 1 diabetes in the 20th century. Diabetes 2002;51(12):3353-61. 
713.  Karjalainen J., Martin JM., Knip M., Ilonen J., Robinson BH., Savilahti E., et al. A bovine albumin peptide as a possible trigger of insulin-dependent diabetes mellitus. N Engl J Med 1992;327:302-7. 
714.  Monte WC., Johnston CS., Roll LE. Bovine serum albumin detected in infant formula is a possible trigger for insulin-dependent diabetes mellitus. J Am Diet Assoc 1994;94(3):314-16. 
715.  Johnston CS., Monte WC. Infant formula ingestion is associated with the development of diabetes in the BB/Wor rat. Life Sci 2000;66(16):1501-7. 
716.  Soltesz G., Patterson CC., Dahlquist G. Worldwide childhood type 1 diabetes incidence--what can we learn from epidemiology? Pediatr Diabetes 2007;6(Suppl):6-14. 
717.  Karvonen M., Viik-Kajander M., Moltchanova E., Libman I., LaPorte R., Tuomilehto J. Incidence of childhood type 1 diabetes worldwide. Diabetes Mondiale (DiaMond) Project Group. Diabetes Care 2000;23(10):1516-26. 
718.  Gloster HM, Brodland DG. The epidemiology of skin cancer. Dermatol Surg 1996;22(3):217-26. 
719.  Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate--United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 2004;53(17):352-5. 
720.  Centers for Disease Control and Prevention (CDC). Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other neural tube defects. MMWR Recomm Rep 1992;41(RR-14):1-7. 
721.  Cragan JD., Roberts HE., Edmonds LD., Khoury MJ., Kirby RS., Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis--United States, 1985-1994. MMWR CDC Surveill Summ 1995;44(4):1-13. 
722.  Choi SW., Mason JB. Folate and carcinogenesis: an integrated scheme. J Nutr 2000;130(2):129-32. 
723.  Jones JG., Bellion E. Methanol oxidation and assimilation in Hansenula polymorpha. An analysis by 13C n.m.r. in vivo. Biochem J. 1991 Dec 1;280 ( Pt 2):475-81. 1991;280(2):475-81. 
724.  Suarez L., Felkner M., Brender JD., Canfield M., Hendricks K. Maternal exposures to cigarette smoke, alcohol, and street drugs and neural tube defect occurrence in offspring. Matern Child Health J. 2008 May;12(3):394-401 2008;12(3):394-401. 
725.  Elwood JM., Coldman AJ. Water composition in the etiology of anencephalus. Am J Epidemiol 1981;113(6):681-90. 
726.  Larsson KS. The dissemination of false data through inadequate citation. J Intern Med. 1995 Nov;238(5):445-50. 1995;238(5):445-50. 
727.  Sever LV. Looking for causes of neural tube defects: where does the environment fit in? Environ Health Perspect. 1995 Sep;103 Suppl 6:165-71. 1995;103(6):165-71. 
728.  Mills JL., Rhoads GG., Simpson JL., Cunningham GC., et. al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. National Institute of Child Health and Human Development Neural Tube Defects Study Group. N Engl J Med. 1989 Aug 17;321(7):430-5. 1989;32(7):430-5. 
729.  Heseker HB., Mason JB., Selhub J., Rosenberg IH., Jacques PF. Not all cases of neural-tube defect can be prevented by increasing the intake of folic acid. Br J Nutr 2009;102(2):173-80. 
730.  Ly A., Lee H., Chen J., Sie KK., Renlund R., et. al. Effect of maternal and postweaning folic acid supplementation on mammary tumor risk in the offspring. Cancer Res 2011;71(3):988-97. 
731.  Schmidt RJ., Hansen RL., Hartiala J., Allayee H., Schmidt LC., Tancredi DJ., et al. Prenatal Vitamins, One-carbon Metabolism Gene Variants, and Risk for Autism. Epidemiology 2011;22(4):476-85. 
732.  Oyedele OO., Kramer B. Acute ethanol administration causes malformations but does not affect cranial morphometry in neonatal mice. Alcohol 2008;42(1):21-7. 
733.  May PA., Gossage JP., Brooke LE., Snell CL., Marais AS., Hendricks LS.Croxford JA., et al. Maternal risk factors for fetal alcohol syndrome in the Western cape province of South Africa: a population-based study. Am J Public Health 2005;95(7):1190-9. 
734.  Madsen KM., Hviid A., Vestergaard M., Schendel D., Wohlfahrt J., Thorsen P., et al. A population-based study of measles, mumps, and rubella vaccination and autism. N Engl J Med. 2002 Nov 7;347(19):1477-82. 2002;347(19):1477-82. 
735.  Ratajczak HV. Theoretical aspects of autism: biomarkers - a review. J Immunotoxicol 2011;8(1):80-94. 
736.  Gillis RF., Rouleau GA. The ongoing dissection of the genetic architecture of Autistic Spectrum Disorder. Molecular Autism 2011, 2:12 Doi:10.1186/2040-2392-2-12 2011;2(12). 
737.  Thompson M. NTP Technical Report on Toxicity Studies of Formic Acid (CAS No: 64-18-6) National Toxicology Program Toxicity Report Series Number 19. United States Department of Health and Human Services; 1992. 
738.  Ratajczak HV. Theoretical aspects of autism: Causes--A Review. J Immunotoxicol 2011;8(1):68-79. 
739.  Courchesne E., Carper R., Akshoomoff N. Evidence of Brain Overgrowth in the First Year of Life in Autism. JAMA 2003;290(3):337-44. 
740.  Jansen GR., Monte WC. Amino Acid Fortification of Bread Fed at Varying Levels During Gestation and Lactation in Rats. J Nutr 1977;107(2):300-9. 
741.  Sun Q., Townsend MK., Okereke OI., Rimm EB., Hu FB., Alcohol Consumption at Midlife and Successful Ageing in Women: A Prospective Cohort Analysis in the Nurses’ Health Study. PLoS Med 1001090 2011;8(9). 
742.  Methanol Institute. Methanol-Institute-Comments-Methanol as a Probable Carcinogen IRIS-Draft-Review-FINA. U.S. Environmental Protection Agency; 2010. 
743.  Gardener H., Rundek T., Markert M., Wright CB., Elkind MS., Sacco RL. Diet Soft Drink Consumption is Associated with an Increased Risk of Vascular Events in the Northern Manhattan Study. J Gen Intern Med. 2012 Jan 27 2012;27. 
744.  Elkind MS., Sciacca R., Boden-Albala B., Rundek T., Paik MC., Sacco RL. Moderate alcohol consumption reduces risk of ischemic stroke: the Northern Manhattan Study. Stroke 2006;37(1):13-9. 
745.  Sacco RL., Elkind M., Boden-Albala B., Lin IF., Kargman DE., Hauser WA., et al. The protective effect of moderate alcohol consumption on ischemic stroke. JAMA 1999;281(1):53-60. 
746.  Hjordís O. Atladottir, Marianne G. Pedersen, Poul Thorsen, Preben Bo Mortensen, Bent Deleuran, William W. Eaton and Erik T. Parner. Association of Family History of Autoimmune Diseases and Autism Spectrum Disorders. 
747.  Blair U. Bradford, Nobuyuki Enomoto, Kenichi Ikejima, Michelle L. Rose, Heidi K. Bojes, Donald T. Forman and Ronald G. Thurman. Peroxisomes Are Involved in the Swift increase in Alcohol Metabolism. 0022-3565/99/2881-0254$03.00/0 THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS. 
748.  Mathew Foster , Robert Zivadinov, Bianca Weinstock-Guttman, Miriam Tamaño-Blanco, Darlene Badgett, Ellen Carl, Murali Ramanathan. Associations of moderate alcohol consumption with clinical and MRI measures in multiple sclerosis. Journal of Neuroimmunology 243 (2012) 61–68. 
749.  William R. Ware. International Health News June, 2012. 
751.  Monique A. Johnson, Hans R. Waterham, Galyna P. Ksheminska, Liubov R. Fayura, Joan Lin Cereghino, Oleh V. Stasyk, Marten Veenhuis, Aleksander R. Kulachkovsky,Andrei A. Sibirny and James M. Cregg. Positive Selection of Novel Peroxisome Biogenesis-Defective Mutants of the Yeast Pichia pastoris. 
753.  Robert Zivadinov,Istvan Pirko. Advances in understanding gray matter pathology in multiple sclerosis: Are we ready to redefine disease pathogenesis?. BMC Neurology 2012, 12:9 doi:10.1186/1471-2377-12-9. 
754.  Hennady P. Shulha, PhD; Iris Cheung, PhD; Catheryne Whittle; Jie Wang, PhD; Daniel Virgil, BS; Cong L. Lin, BS; Yin Guo, MD; Andree Lessard, PhD; Schahram Akbarian, MD, PhD; Zhiping Weng, PhD . Epigenetic Signatures of Autism. 
755.  Erin Green, Claire Murphy. Altered processing of sweet taste in the brain of diet soda drinkers. 
756.  Brent R. Ekins, PharmD; Douglas E. Rollins, MD, PhD; Douglas P. Duffy, MD., and Martin C. Gregory, DPhil, MRCP, Salt Lake City. Standardized Treatment of Severe Methanol Poisoning With Ethanol and Hemodialysis. 
757.  Peizhong Maoa and P. Hemachandra Reddya. Is multiple sclerosis a mitochondrial disease?. Biochim Biophys Acta. 2010 January ; 1802(1): 66–79. doi:10.1016/j.bbadis.2009.07.002.. 
758.  U.S. Department of Health and Human Services. FINAL Report on Carcinogens Background Document for Formaldehyde. 
759.  Airas L, Paavilainen T, Marttila RJ, Rinne J.. Methanol intoxication-induced nigrostriatal dysfunction detected using 6-[18F]fluoro-L-dopa PET... [Neurotoxicology 2008 Jul;29(4):671-4. Epub 2008 Apr 11. 
760.  Sameer Vyas, Neeraj Kaur, Navneet Sharma, Paramjeet Singh, Niranjan Khandelwal . Methanol poisoning with necrosis corpus callosum. 
761.  Gonul Tezcan Keles, Sebnem Orgus, Baris Toprak, Sabri Ozaslan, and Melek Sakarya. Methanol poisoning. 
762.  Vaneckova M., Kalincik T., Krasensky J, Horakova D, Havrdova E, Hrebikova T, Seidl Z. Corpus callosum atrophy - a simple predictor of multiple sclerosis progression: a longitudinal 9-year study.Eur Neurol. 2012;68(1):23-7. Epub 2012 Jun 6. 
763.  Minoru Oishi, Kenji Miki, Akihiko Morita, Kazumi Fujioka, Shigeki Aoki, Ichizo Nishino, Ikuya Nonaka, Yu-ichi Goto and Tomohiko Mizutani. Mitochondrial Encephalomyopathy Associated with Diabetes Mellitus, Cataract, and Corpus Callosum Atrophy. 
764.  Burton Drayer, Peter Burger, Baffle Hurwitz, Deborah Dawson, John Cain. Reduced Signal Intensity on MR Images of Thalamus and Putamen in Multiple Sclerosis: Increased Iron Content?. May/June 1987 issue 0fAJNR and the August 1987 issue of AJR. 
765.  Virginia Elderkin-Thompson, PHD; Gerhard Hellemann, PHD.,Rakesh K. Gupta, MD.,Anand Kumar, MD. Biophysical Correlates of Cognition Among Depressed and Nondepressed Type 2 Diabetic Patients. 
766.  Dagmar Galter., Andrea Carmine., Silvia Buervenich., Gregg Duester and Lars Olson. Distribution of class I, III and IV alcohol dehydrogenase mRNAs in the adult rat, mouse and human brain. Eur. J. Biochem. 270, 1316–1326 (2003)  FEBS 2003. 
767.  Dimitrios  Trichopoulos, Christina  Bamia,Pagona  Lagiou,Veronika  Fedirko,Elisabeth  Trepo,Mazda  Jenab,Tobias  Pischon, Ute  Nöthlings, Kim  Overved, Anne  Tjønneland, Malene  Outzen, Francoise  Clavel-Chapelon, Rudolf  Kaaks, Annekatrin  Lukanova, Heiner  Boeing, Krasimira  Aleksandrova, Vassiliki  Benetou, Dimosthenis  Zylis, Domenico  Palli, Valeria  Pala, Salvatore  Panico, Rosario  Tumino, Carlotta  Sacerdote, H. Bas  Bueno-De-Mesquita, Henk J.   Van Kranen, Petra H.M. Peeters, Eiliv  Lund, J. Ramón  Quirós, Carlos A. González, Maria-Jose  Sanchez Perez, Carmen  Navarro, Miren  Dorronsoro, Aurelio  Barricarte, Björn  Lindkvist, Sara  Regnér, Mårten  Werner, Göran  Hallmans, Kay-Tee  Khaw, Nick  Wareham, Timothy  Key, Isabelle  Romieu, Shu-Chun  Chuang, Neil  Murphy, Paolo  Boffetta, Antonia  Trichopoulou, Elio  Riboli . Hepatocellular Carcinoma Risk Factors and Disease Burden in a European Cohort: A Nested Case–Control Study. 
768.  Nursel Türkmen, Bulent Eren, G?rsel Cetin. FATAL METHANOL INGESTION IN A CHILD; CASE REPORT - (severe brain swelling picture). 
769.  Newcombe J, Li H, Cuzner ML. Low density lipoprotein uptake by macrophages in multiple sclerosis plaques; implications for pathogenesis.Neuropathol Appl Neurobiol. 1994 Apr;20(2):152-62. 
770.  María I Gaitán, Pascal Sati, Souheil J Inati and Daniel S Reich . Mult Scler 2012 Gaitán Initial investigation of the blood-brain barrier in MS lesions at 7 tesla. Multiple Sclerosis Journal. 
771.  Kun Lu, Husamettin Gul, Patricia B. Upton, Benjamin C. Moeller, James A Swenberg., . Formation of Hydroxymethyl DNA Adducts in Rats Orally Exposed to Stable Isotope Labeled Methanol. Sci.-2011-Lu-toxsci_kfr328. 
772.  Haffner HT, Graw M, Besserer K, Blickle U, Henssge C. Endogenous methanol: variability in concentration and rate of production. Evidence of a deep compartment?. Institute of Forensic Medicine, University of Essen, Germany. 
773.  Olivier De´sy, Damien Carignan, Manuel Caruso, Pedro O. de Campos-Lima . Methanol Induces a Discrete Transcriptional Dysregulation that Leads to Cytokine Overproduction in Activated Lymphocytes. TOXICOLOGICAL SCIENCES 117(2), 303–313 (2010). 
775.  Fagherazzi G, Vilier A, Saes Sartorelli D, Lajous M, Balkau B, Clavel-Chapelon F . Consumption of artificially and sugar- sweetened beverages and incident type 2 diabetes. Am J Clin Nutr. 2013 Mar;97(3):517-23. 
776.  Pa°l Sure´n, MD, MPH;Christine Roth, MSc;Michaeline Bresnahan, PhD; Margaretha Haugen, PhD; Mady Hornig, MD; Deborah Hirtz, MD; Kari Kveim Lie, MD; W. Ian Lipkin, MD; Per Magnus, MD; PhD; Ted Reichborn-Kjennerud, MD, PhD; Synnve Schjølberg, MSc, George Davey Smith, MD, DSc.,Anne-Siri Øyen, PhD, Ezra Susser, MD, DrPH.,Camilla Stoltenberg, MD, PhD. Association Between Maternal Use of Folic Acid Supplements and Risk of Autism Spectrum Disorders in Children. 
777.  Hayasaka Y, Hayasaka S, Nagaki Y . Ocular changes after intravitreal injection of methanol, formaldehyde, or formate in rabbits. 
779.  Polly A. Newcomb, Ellen Kampman, Amy Trentham-Dietz, Kathleen M. Egan, Linda J. Titus,John A. Baron, John M. Hampton, Michael N. Passarelli and Walter C. Willett . Alcohol Consumption Before and After Breast Cancer Diagnosis: Associations With Survival From Breast Cancer, Cardiovascular Disease, and Other Causes. 
780.  CCY Wong, EL Meaburn, A Ronald, TS Price, AR Jeffries, LC Schalkwyk, R Plomin. and J Mill. Methylomic analysis of monozygotic twins discordant for autism spectrum disorder and related behavioural traits. Molecular Psychiatry (2013), 1–9. 
781.  Li Y, Lee PY, Reeves WH . Monocyte and macrophage abnormalities in systemic lupus erythematosus. Arch Immunol Ther Exp (Warsz). 2010 Oct;58(5):355-64. 
782.  Diana L. Vargas, MD, Caterina Nascimbene, MD, Chitra Krishnan, MHS, Andrew W. Zimmerman, MD and Carlos A. Pardo, MD. Neuroglial Activation and Neuroinflammation in the Brain of Patients with Autism. Ann Neurol 2005;57:67–81.